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Introduction 
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INTRODUCTION 
 Uterus is a vital reproductive organ subjected to many benign and 
malignant lesions which commonly results from various hormonal imbalances. 
The myometrium of uterus is composed of bundles of smooth muscle that form 
the wall of the uterus. The inner cavity of the uterus is lined by the endometrium 
composed of glands embedded in a cellular stroma1. The endometrium is a 
dynamic tissue that undergoes physiologic and characteristic morphologic 
changes during the menstrual cycle as a result of the effect of sex steroid hormones 
like estrogen and progesterone produced in the ovary. A myriad array of 
compounds has been identified in the endometrium include enzymes, hormones 
and bioactive peptides. 
 Normal values for endometrial thickness range from 2 to 16 millimeters, 
depending on the stage of the menstrual cycle. “Dating” the endometrium by its 
histologic appearance is often used clinically to assess hormonal status, document 
ovulation, determine causes of endometrial bleeding and infertility7. The cycle 
begins with the shedding of the upper half to two thirds of the endometrium, 
referred to as the functionalis, during menses. Under the influence of estrogen, 
produced by the granulosa cells of the developing follicle in the ovary, the 
remaining third (basalis) undergoes extremely rapid growth of both glands and 
stroma.  
 According to World Health Organization reproductive age group is defined 
as 15-49 years. The various endometrial lesions including chronic endometritis, 
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endometrial polyps, hyperplasia and malignancies which present with abnormal 
uterine bleeding. Adenomyosis is the most common tumor like condition 
involving the myometrium.It is described as presence of widely-distributed 
endometrial glands or stromal tissue in the myometrial layer of uterus. 
 Adenomyosis consists of both epithelial and stromal elements, and is 
located about 2 to 2.5mm below the endomyometrial junction1. Furthermore, 
leiomyomas are frequently associated with adenomyosis hindering the differential 
diagnosis. Adenomyosis has been difficult to diagnose without the surgical 
pathology of a hysterectomy specimen. Uterine leiomyomas account for more 
than 75% of the benign tumors in women of reproductive age group. Studies have 
suggested that numerous hormones, growth factors, cytokines and other signal 
transduction pathways have a role in the pathogenesis of leiomyoma. Estrogen 
and estrogen-related genes might play a predominant role in the growth rate of 
leiomyomas. The normal myometrium of uteri expresses higher levels of estrogen 
receptors which is related to pathogenesis. The leiomyoma is composed of smooth 
muscle and fibrous tissue and are benign in nature.Based on their location within 
the uterine wall, leiomyomas are classified into submucosal or subendometrial, 
intramural or myometrial and subserosal leiomyomas. The latter may be 
pedunculated and simulate adnexal masses. 
 Most of the leiomyomas undergo secondary changes in approximately 65% 
of cases. These include hyaline degeneration (63%), myxoid changes (19%), 
calcification (8%), cystic changes(4%), and fatty metamorphosis (3%)1. The 
leiomyosarcoma is the malignant counterpart of the leiomyoma and is the most 
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common pure sarcoma of the uterus. Hysterectomy is the most common 
gynecological procedure performed for the management of leiomyomas, 
adenomyosis, abnormal uterine bleeding, endometriosis and utero-vaginal 
prolapse. Histopathological examination of hysterectomy specimens carries 
diagnostic and therapeutic significance. Hence this study made an attempt to study 
the histopathological changes in endometrium with associated myometrial lesions 
in hysterectomy specimens. 
 
 
 
 
 
 
 
 
 
 
  
  
 
  
 
Aims &  Objectives 
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AIMS AND OBJECTIVES 
1.  To study the changes of endometrium in association with myometrial 
lesions of hysterectomy specimens with respect to various clinical and 
morphological features. 
2.  To analyse the histopathological changes of endometrium in association 
with myometrial lesions of hysterectomy specimens in our Institution with 
respect to LMP, age. 
3.  To assess the age distribution of the myometrial lesions in patients 
subjected to hysterectomy.  
4.  To assess the endometrial changes in relation with the types and sites of 
myometrial lesions in hysterectomy specimens. 
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HISTORICAL REVIEW 
EMBRYOLOGY AND HISTOGENESIS 
The genito urinary system is developed from the urogenital ridge after 21st 
day of fertilization1. The end term of embryo forms the primitive gut which is 
attached to the posterior wall of the body cavity by a mesentery. On either side of 
the mesentery, the posterior wall is made up of intraembryonic mesoderm. 
Urogenital ridge mullerian ducts develops from the lateral side of this inter 
mediate cell mass 1. This forms the most of the female genital tract on the 
mesonephros.This happens by the invagination of coelemic epithelium. By the 8th 
week they grow caudally and cross entering to the wolffian duct and the 
gubernaculums.They fuse in the mid line and end at the roof of the urogenital sinus 
form an elevation called mullerian tubercle. On each side the cranial longitudinal 
part forms uterine tube and its coelomic opening develops into the fimbrial end1. 
The unfused intermediate part of duct expands and finally fuse to form fundus and 
the body of the uterus. 
 
Figure 1 – Development of Female genital system 
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ANATOMY 
The weight of an adult uterus is about 30 to 50 grams on average. These 
measurements are subjected to individual variations. The average length ranges 
from 5 to 7 cm. Its greatest depth is 3 cm. The body of uterus comprises of an 
anterior wall, a posterior wall along with fundus and the lateral margins. The 
narrow triangular space in the body of the uterus is called as endometrial cavity. 
The interior limit of the fundus is the base of the triangle while the angle lies at 
the internal os of the cervix1,42. The communication between endometrial cavity 
and the fallopian tube is through the right and left cornua.  
 
Figure 2 – Anatomy of Uterus 
APPLIED HISTOLOGY 
The histological architecture of the body of the uterus is characterized by 3 
layers. They are 
1.  Outer Serosal layer  
7 
2.  Middle Myometrial layer   
3.  Inner Endometrial layer       
 The serosal layer extends to point of peritoneal reflection and is identical 
with the peritoneum1, 43.The myometrium is composed of fibres that are arranged 
in interlacing bundles between the strands of interstitial connective tissue. The 
endometrium is made up of glands and stroma.It is divided into deeply seated 
basal layer and superficial functional layer.The basal layer is equivalent of reserve 
cell layer and is responsible for regeneration of endometrium following 
menstruation.The functional layer is subdivided into the compactum and 
spongiosum.Characteristic changes take place in the endometrium during the 
different stages of menstrual cycle 1,34. 
HISTOLOGY OF ENDOMETRIUM 
 
Figure 3 – Histology of Endometrium 
 Endometrium is composed of two layers. They are stratum basalis which is 
the basal thin layer and stratum functionalis, the superficial thick layer. These 
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layers are formed by glands that are held together by connective tissue called as 
endometrial stroma. The stroma consists of embryonic type highly cellular 
connective tissue composed of blood vessels and nerves. The two layers of 
endometrium are distinguished by the arrangement of blood vessels. The stratum 
functionalis is shed during menstruation and stratum basalis is permanent 1,23. The 
arteries from the arcuate -> radial -> straight artery enter into the basal layer. As 
they progress more apically they becomes tortuous and finally gives off numerous 
branches. The capillaries end in capillary bed that includes lacunae which are thin 
walled dilated segments present at the superficial portion of stratum functionalis. 
(Ross et al, 1995). The surface epithelium is less responsive to hormonal stimuli 
whereas the functionalis layer is more responsive to hormonal stimuli 1,39.  
 
Figure 4 – Blood supply to Uterus. 
THE GLANDULAR EPITHELIUM 
 The glandular epithelium is a single layer of columnar epithelial cells. 
Their height varies depending upon the functional state ranging from 6 
postmenstrual to 20 at the end of proliferative phase2,43. During the proliferative 
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phase, the glandular cells have enlarged nuclei and dense chromatin. Between the 
10th and 16th day of the menstrual cycle, their DNA content reaches to its 
maximum (Voker, 1951). During the secretory phase, the nuclei becomes round 
and vesicular. The nuclei have abundant RNA. After ovulation, the RNA content 
of the cytoplasm reaches its greatest concentration. The nucleoli of early 
proliferative phase are finely granular and compact2,29. They enlarge as midcycle 
is approached and reach 2.8 in diameter (Fassake et al, 1965). During the first 
week of the secretory phase, the nucleoli has a characteristic tubular or meshwork 
like structure and the nucleolar channel system which is embedded in an electron 
dense matrix and contains RNA2,42. It serves the exchange of protein between 
nucleolus and cytoplasm for enzyme synthesis (Dubauszky and Pohlmann, 1960, 
Armstrong et al, 1973). This channel system apparently occurs only in the human 
endometrium and seems to depend on adequate levels of progesterone2,42. It can 
be demonstrated by electron microscopy shortly before ovulation. 
 During the proliferative phase, the cytoplasm is unusually rich in RNA 
content and is demonstrated by the histochemical techniques (Wislocki and 
Dempsey, 1945) or by fluorescence microscopy (Dallenbach and Dallenbach – 
Hellweg, 1968). The cytoplasm of the basal part of the cell contains abundant 
ribosomes (Borell et al, 1959), bundles of tonofilaments each about 100 diameter 
appear around the 13th day of the menstrual cycle under the influence of increased 
estrogen stimulation3,9. They stabilize the rigidity of cells prior to nidation 
(Clyman et al, 1982). With the onset of secretory phase, the mitochondria multiply 
and enlarge at the base of the cell near the first aggregate of glycogen. Then, 
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abundant basal secretory granules collect around smooth endoplasmic 
reticulum3,29. As glycogen, mucopolysaccharides and proteins also accumulate at 
the lower pole of the nucleus to form cloudy or granular deposits. The large 
mitochondria nearby swells to giant size and may reach 7 in diameter. On the 
17th day of the menstrual cycle, glycogen is found scattered throughout the 
cytoplasm3,43. With the onset of secretion on 19th and 20th day of menstrual cycle, 
the cytoplasm along the luminal surface sends out enlarged microvilli filled with 
secretory products3,9. Thereafter the apical portion of the cell is discharged into 
the lumen. Thus, the epithelial cell expels their products by apocrine secretion and 
thereby becomes smaller. The glycogen is thought to serve a complex function 
involving more than pure glandular secretion (Sakuma, 1970). 
 Sometimes ciliated columnar cells are found among the glandular epithelial 
cell (Mandl, 1911). These ciliated cells initially lie against the basement 
membrane. Because of their abundant translucent cytoplasm they can be readily 
recognized as a “clear cell”. The rounded nucleus of the clear cells are generally 
located above those of the neighbouring epithelial cells (Feyrter and Froewis, 
1949). ‘Clear cells’ are possibly the precursor cells in the proliferative phase and 
in cystic glandular hyperplasia. Around midcycle of the cycle and in endometrial 
hyperplasia, there are numerous fully developed ciliated cells. (Maddi and 
Papanicolaou, 1961). 
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Figure 5 – Glandular epithelium 
THE SURFACE EPITHELIUM 
 During the proliferative phase, the superficial epithelium closely resembles 
the glandular epithelium although it contains greater number of ciliated cells 
(Ferenczy et al, 1972). Glycogen appears in large amounts earlier and remains 
longer than in glandular epithelium. The superficial epithelium differs from 
glandular epithelium functionally 3,38. The secretion of surface epithelium is 
important for the adherence and implantation of blastocyst. Scanning Electron 
Microscopy reveals the accumulation of the ciliated cells around the mouths of 
the glands 3,7(Hafez et al, 1975). During the secretory phase, these cilia degenerate. 
The size and number of their microvilli decrease as the apical surface of the cell 
continues to bulge into the uterine cavity 3,9. 
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Figure 6 – Surface epithelium and stroma 
THE STROMAL CELLS 
 The endometrial stroma consists of pluripotent mesenchymal cells which 
are uniformly spindle shaped, poorly differentiated at the beginning of the 
menstrual cycle. They are joined to one another by cytoplasmic processes. The 
cells are anchored firmly within a delicate network of reticulin fibers. They have 
elongated nuclei with abundant chromatin. At the beginning of the menstrual 
cycle, the cytoplasm of these cells forms a narrow rim around the dark nuclei. The 
nuclear substance becomes less dense, the nucleoli grow larger and more 
conspicuous and the nuclear membrane becomes wrinkled at the end of the 
proliferative phase. There is accumulation of RNA in the cytoplasm of the more 
superficial stromal cells. The Golgi apparatus and mitochondria remains poorly 
developed3,9. The microfibrils of collagen become apparent not only within the 
cell but also outside of them. Also there is expansion of smooth and rough 
endoplasmic reticulum (Wetzstein and Wagner, 1960). 
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 During the secretory phase there is increase in number of mitochondria and 
smooth endoplasmic reticulum and the Golgi apparatus enlarges. Vacuoles and 
granules start appearing in the expanding and shortened microvilli. The glycogen 
and glycoproteins are in diffuse and granular form from the 20th day of the cycle 
onwards3,7. This can be demonstrated in the cytoplasm of the stromal cells with 
the help of electron Microscopic and histochemical methods (Mckay et al, 1956). 
Some stromal cells contain fine lipid droplets (Aschheim 1915) which are said to 
appear after estrogen stimulation. The lipid accumulates in large amounts and the 
stromal cell may reach the size of decidual cells to acquire a foamy appearance3,9. 
 By the end of the secretory phase, the endometrial granulocytes 
accumulates. These cells are smaller than the decidual cells with a crenated 
nucleus (Nordquist, 1970) and contains relatively large lysosomal granules31,41 
These are originally thought to be derived from the stromal cells (Dallenbach – 
Hellweg, 1981) and thought to secrete a proteolytic hormone called relaxin 
(Dallenbach & Dallenbach – Hellweg, 1964). It has now been shown that these 
endometrial granulocytes are a population of large granular lymphocytes which 
are probably derived from the bone marrow and have characteristics of natural 
killer cells (Bulmer et al, 1987). They play a important role in successful 
implantation and placentation 1 (Ritson and Blumer, 1987). These cells contain 
phloxinophilic granules in the cytoplasm (Hamperl, 1954, Hellweg, 1954). These 
cells are also called as stromal granulocytes or endometrial granulated 
lymphocytes. They show CD59 & CD69 positivity3,24,30.  
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OTHER CELLS IN ENDOMETRIUM 
 In non-inflamed endometrium lymphocytes appear frequently. Lymphoid 
follicle formation in the endometrium is not unusual (Monch, 1918). Histiocytes 
and mast cells are also found in the endometrium. Plasma cells and eosinophils 
are found very rarely (Feyrter, 1957). 
THE RETICULIN FIBRES 
 The distribution of reticulin fibres varies in the endometrium. The stroma 
of the basalis and the isthmic mucosa remains uniformly dense. The fibre content 
of the functionalis layer fluctuates during the menstrual cycle (Hormann, 1908, 
Hoffmeister and Schulz, 1961). During the first 8 days of the proliferative phase, 
only occasional delicate reticulin fibres are seen with the light microscopy. Once 
ovulation approaches, these fibres become denser and thicker. By the 4th week of 
the menstrual cycle, the fibres enmesh each predecidual cell and form a dense 
network around the glands and the spiral arterioles. When the progesterone 
decreases, there is disintegration of reticulin fibres3,29. As a result the glands 
separate from stroma and stromal cells dissociate from one another. The functional 
state of endometrium can be evaluated from the appearance and quality of 
reticulum network (Vaczy and Scipiades, 1949). 
THE GROUND SUBSTANCE 
 The ground substance of the endometrium bathes the cellular and fibrous 
components of endometrium. It chiefly contains high molecular neutral and acid 
mucopolysaccharides in the early and mid proliferative phase of the cycle. The 
ground substances begin to resolve into subgroups of low molecular size in the 
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late proliferative phase. It appears oedematous as the time of implantation 
approaches in the midsecretory phase. High molecular, neutral and acid 
mucopolysaccharides reaccumulate in the compacta and around the spiral 
arterioles during 4th week of menstrual cycle. These changes are essential for the 
implantation of blastocyst. 
THE VESSELS 
 The vessels of the stratum functionalis differ from the blood vessels of 
other organ and tissues by their sensitivity to hormones, their unique structure and 
their ability to respond quickly to such stimuli (Ramsey, 1955, Nieminen, 1962). 
In contrast, the vessels of the stratum basalis are influenced only little by hormonal 
changes of the cycle. At the end of proliferative phase, the spiral arterioles of the 
stratum functionalis that branch from the arteries of the basalis finally attains the 
upper portion of the endometrium. Progesterone stimulates these vessels to grow 
larger and longer imparting tortuosity. These changes are especially evident when 
the ratio of the height of endometrium to the length of the spiral arteries is 1:15 
during the second half of the secretory phase (Markee, 1950). The arteries undergo 
extensive spiraling because they grow at faster rate when compared to the 
endometrium. Their wall which is thin in the early proliferative phase grows 
progressively thicker (Wiegand, 1930, Farrer – Brown et al, 1970). The lining 
endothelial cells which are originally flat now swells and soon contain large, 
vesicular nuclei (Keller, 1911). The capillaries of the functionalis also respond to 
harmonal variations. Just beneath superficial epithelium, they branch and pass and 
becomes the largest in premenstrual phase and in decidua of pregnancy. They form 
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a lacuna like sinusoids which are called as anastomosing lacuna of Schmidt - 
Matthiesen (Schmidt – Matthiesen, 1962). 
 The veins of stratum functionalis also respond to the hormonal stimuli of 
secretory phase, as other vessels (Küstermann, 1930). The venous network of the 
endometrium is strikingly dense. Beneath the superficial epithelium, they form 
thin walled “lakes”3. 
PHYSIOLOGICAL ACTION OF HORMONES ON ENDOMETRIUM 
 Though Andreas Vesalius in 1545 explained about the pituitary and 
hypothalamus relationship, only in 1947 Green and Harris together recognized it 
as a neurovascular complex3,7. The gonadotrophin hormones are discovered by 
Ascheim and Zondek in 1927.In 1931, Fevold, Hisaw and Leonard described the 
FSH and LH. But the normal physiological sequence of events in menstrual cycle 
in relation to pituitary and ovary was described only in 1971 by Speroff, Van de 
wiele and Newton et al. Later on, in 1973 Fraser et al found irregular menstrual 
cycles are due to FSH & LH deficiency3,35. 
HORMONAL CONTROL OF OVULATION 
 Ovulation depends upon complex interrelationship between hypothalamus, 
pituitary and ovary. The gonadotrophin releasing hormones (FSH / LH – RH) that 
are carried in the hypophyseal vessels to the anterior pituitary, stimulates the 
synthesis and release of FSH and LH into the general circulation. These hormones 
are necessary for the growth of the follicles and maturation in the ovary4,35. 
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Figure 6 – Hypothalamus – Pituitary Axis 
 During the midcycle, there is an additional surge of LH release which 
causes the FSH primed follicle to rupture and the release of ovum. The ruptured 
follicle is then transformed into corpus luteum which synthesizes the hormones 
(progesterone and estrogen). These steroidal hormones of ovary inhibit the 
stimulation of ovary by gonadotrophin by negative feedback mechanism taking 
place in Hypothalamo - Pituitary axis. If the fertilization does not occur, the corpus 
luteum remains transient, involutes, ovarian hormone decreases in quantity and 
then the menstruation follows. The hypophysis then resumes their function and 
the cycle repeats itself 4. 
  
18 
HORMONAL LEVELS IN NORMAL MENSTRUAL CYCLE 
 
Figure 8 - HORMONAL LEVELS IN NORMAL MENSTRUAL CYCLE 
ENDOMETRIAL STEROID RECEPTORS 
The steroid hormones trigger their activity through specific receptor sites 
expressed on the target cells. They are carried from the receptor to the nucleus and 
to genes to induce the process of transcription and translation resulting in cell 
proliferation and differentiation4 (Gorski and Gannon, 1976). 
 In the stratum functionalis, there is fluctuation of receptors for estrogen and 
progesterone during the menstrual cycle (Bayard et al, 1978). When the estrogen 
receptor remains unoccupied by estrogen in the nucleus, it is loosely bound in the 
monomer state4,36. When the estrogen binds, there is activation leading to the 
formation of a dimer (Scholls, 1984). One aspect of the activation is an increased 
affinity for estrogen4. This increase in affinity is called as positive cooperativity, 
which increases the ability of the receptors to respond to small changes in the 
concentration of hormone. The mechanism of action is same in case of 
progesterone (Edwards et al, 1969). The concentration of estrogen and 
19 
progesterone receptors in the fundal region is higher than in the middle and isthmic 
portion of the uterus 4,18. The basalis layer has a constant receptor number and the 
binding is independent of the phase of menstruation4,12.  
 The effect of the hormones on epithelial, stromal and endothelial cells is 
mediated by estrogen receptor (ER) and progesterone receptor (PR).The 
regulation of EGF receptor content is achieved by secretion of ovarian hormone 
4,7 (Ferenczy, 1994). The receptors which are synthesised in the cytoplasm get 
transported into the nucleus by a dimer of heat shock protein (hsp – 90)5,18. With 
the formation of hormone receptor complex, there is dissociation of hsp – 90. In 
the early proliferative phase, there is gradual increase in estradiol receptors. The 
progesterone receptors are fewer in number when compared to estrogen 
receptor5,29. 
 In the late proliferative phase there is increase in the concentration of total 
estradiol receptors. The cytoplasmic receptors increase greatly in number 
correlating with the surge of plasma estradiol. After ovulation, the total estradiol 
receptors decrease rapidly in the early secretory phase5,18.  
ESTROGEN 
 In contrast to other steroid hormones, even minute amount of estrogen is 
very potent and is capable of producing rapid, significant changes in the target 
cells. In endometrium, both stromal and glandular cells respond actively to 
estrogen. Estrogen regulates the amount of genetic material which are available 
for transcription resulting in cell proliferation seen as mitosis4. The first change in 
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the glandular and stromal cells of endometrium is the increase in amount of RNA 
in the nuclei and nucleoli followed by the increase in cytoplasmic RNA 
(Davidson, 1965). Finally the endometrial cells cease to proliferate with the 
secretion of progesterone5. 
PROGESTERONE 
 In the human endometrium the first evidence of effect of progesterone is 
detectable with the light microscope only after 36 hours. The changes noted are 
clearing of the nuclei of glandular epithelial cells and appearance of granules of 
glycogen at the base of the glandular epithelial cells5,30,32. In Electron Microscopic 
studies, giant mitochondria which contains DNA near the glycogen granules are 
found (Merker et al, 1968). The progesterone stimulates the mitochondria in 
synthesizing proteins. Later, under the influence of progesterone, a nuclear 
channel system is developed. There is cessation of mitotic activity. There is 
production of glycogen, neutral and acid mucoploysaccharides and lipids by the 
glandular cells. By the 2nd week of the secretory phase, the stromal cells start 
differentiating into large predecidual cell5,36. 
THE NORMAL MENSTRUAL CYCLE 
 The first histological description of the cyclical changes in the 
endometrium was done by Hitschmann and Adler (1908). 
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Figure 9 – Normal menstrual cycle 
 However, Noyes et al in 1950, first described in detail on “dating of 
endometrium” from histological criteria, that is on how to diagnose how far an 
endometrium has developed in the menstrual cycle from the characteristic 
histological changes that occur at specific times. Moricard in 1954 and Philippe 
et al in 1965 confirmed the data of Noyes et al. The menstrual cycle divided into 
three phases. They are 
 1. Proliferative phase 
 2. Secretory phase and 
 3. Menstrual phase 
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PROLIFERATIVE PHASE 
 The endometrium regenerates from the basal layer and the part of the 
functionalis layer, which remains after menstruation. The epithelium actively 
covers the denuded surface. There is no evidence of mitotic activity in the early 
stages of regeneration. Upon the hormonal stimulus the initial resurfacing occurs 
independently. The normal proliferation lasts for about a period of two weeks. But 
there is variation in time taken for the development of follicle from women to 
women and between cycle to cycle. Therefore, it is impossible to date the 
proliferative phase with any accuracy and it is divided into 3 phases -early, mid 
and late proliferative phase. In the early stages, the glands are lined by low 
columnar epithelial lining measuring 6 in height and appears as simple tubules. 
Both in the glands and stroma, there is evidence of mitotic activity. The stroma is 
loosely packed and composed of spindle cells. 
 In the mid proliferative phase, there is elongation of glands continue and 
the stromal edema develops. The elongation of the glands outstrips the stromal 
edema and consequently the glands acquire tortuousity. In the late proliferative 
phase, the edematous stroma subsides and the tortuosity of the glands increases. 
There is maximum mitotic activity in the glands and stroma which corresponds to 
the preovulation peak of the estrogen. There is pseudostratification of glandular 
epithelium due to the heaping up of columnar epithelium14. The glandular cells 
measure 20µ in height. There is distension of lumen. Small amount of glycogen 
vacuoles are found in the cells. As the proliferative phase progresses, nucleoli in 
the glandular cells become more prominent6,14. Over the period, the individual 
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stromal cells show only little change other than growth and appear to contain little 
amount of cytoplasm in H & E sections (naked nuclei appearance).  
 
Figure 10 – Proliferative phase 
SECRETORY PHASE   
 Secretory phase is divided in to three phases. They are: 
 1. Early secretory phase 
2. Mid secretory phase and 
3. Late secretory phase 
 In the glandular epithelium, subnuclear vacuolation occurs 36 – 48 hours 
after ovulation. It is considered as one of the early signs of ovulation when the 
majority of the cells show subnuclear vacuolation. On 16th -19th day of cycle, the 
secretions of the subnuclear vacuoles gradually moves to the apical pole of the 
cells and nucleus takes up a basal position. By the 16th day of cycle, there is loss 
of glandular pseudostratification. For some 2 – 3 days after ovulation, mitotic 
activity is still apparent and continues in the glands. The secretions make the cells 
to lose their dividing ability. Mitosis is absent after 19th day6. During ovulation, 
the epithelial cells express B72 and 32 very late antigens – 1. (Ferenczy, 1994) 
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 The secretions accumulate at the apical poles of the cells and protrude as 
blunt projections into the gland lumen, becoming pronunced by day 21 of the 
cycle. As the secretory material is shed by the apocrine method, the epithelial 
surface assumes irregular shaggy appearance.There is dialation of the gland 
lumens by the secretory material. Secretory activity continues for several days 
post ovulation. If pregnancy does not ensue, there is decline in secretory activity 
after day 22. The secretory activity varies in different parts of endometrium. There 
is involutional changes of the glands and there is inspissation or gradual 
disappearance of luminal secretions. The glands collapse progressively and 
papillary tufts of epithelium project into the lumen, giving rise to characteristic 
saw toothed appearance7,8.  
 Thereafter the glands show various degenerative changes with ragged 
epithelial cell borders along with the appearance of apoptosis and giant 
autophagocytic lysosomes. During the second half of the secretory phase, typical 
changes occurs in stroma. If pregnancy has not ensued, there is involution of 
corpus luteum and there is fall in plasma progesterone levels. The estrogen levels 
which falls temporarily after ovulation reaches a second peak by the day 21 and 
22. The stromal oedema begins apparent during this period of maximal estrogen 
stimulation. Increase in the level of estrogen is associated with vascular 
endothelial swelling and increased endothelial capillary lining fenestration7. 
These changes are brought about by Prostaglandin F2 (PGF2) and Prostaglandin 
E2. (Ferenczy, 1980, Smith et al, 1983).  
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 The oedema subsides by 23rd day. There is prominent spiral arteriole. This 
is because of increase in length of the arterioles. The predecidual changes occurs 
in the stromal cells immediately adjacent to these vessels. There is enlargement of 
stromal cells to acquire a polygonal shape with small rounded nuclei. The 
cytoplasm is copious and there is accumulation of glycogen and lipid. These 
changes cause the separation of the endometrium. During the last two days of the 
menstrual cycle prior to menstruation, there is accumulation of granulocytes in the 
endometrial stroma7.  
 
Figure 11- Secretory phase 
MENSTRUATION  
 At the end of each cycle, if pregnancy has not ensued appropriate 
proportion of the endometrium is shed. Together with blood inspissated, secretory 
material and other debris makes up the menstrual flow. Usually lasts for some four 
days. This process is related to the hormonal levels. There is deficiency in both 
estrogen and progesterone levels in the later stages of the cycle (Zuckerman, 
1949). Also the hormones cause fluid loss in the endometrium and it shrinks 
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(Markee, 1950). Approximately 30% of the bulk is lost. With further reduction in 
blood flow, this shrinkage causes further coiling of the spiral arterioles. Thus, 
shrinkage causes the glands become closer and gives an impression of increased 
cellularity. This is heightened by the endometrial stromal granulocytes and 
leucocytes accumulating at this stage. Immediately preceding the menstruation , 
the spiral arteriole constricts by the shrinkage of endometrium along with 
blanching of the overlying epithelium. It is suggested that reduction in the 
circulating progesterone-estrogen concentration below some critical level triggers 
the effect on spiral arterioles (Zuckerman, 1949 loc cit). In due course of time, 
these vessels dilate and the damaged vessel wall enables the erythrocytes to pass 
through. As a result of this, small haematoma is formed beneath the surface, 
raising blebs. The blood comes to lie directly on the surface when the necrotic 
epithelium is shed. Thus, the shedding of endometrium starts superficially and 
proceeds to the deeper layers following which rapid disintegration occurs. The 
endometrium is usually shed in a piecemeal fashion and occasionally shed in 
larger fragments. The stroma is heavily infiltrated by acute inflammatory cells8,9.  
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Figure 12 – Menstrual phase 
  
Figure 13 – Summary of cyclical changes 
VARIATION IN MENSTRUAL CYCLE 
 There is considerable variation in length of the cycle in different women. 
The mean is 29.6 days. There is a tendency for decrement in mean cycle length 
with age (Treloar et al, 1967). Any menstruation beyond this limit, any bleeding 
28 
inbetween the menstrual cycle and any premenopausal acyclical bleeding are 
considered abnormal. The menstrual bleeding duration also exhibit variation from 
2 to 7 days with a mean of 5 days (Guillebaud and Bonnar, 1978). Any 
menstruation lasting for 8 days or longer is regarded as excessive. The average 
blood loss in menstruation is about 80ml/cycle (Hallberg et al, 1966). Blood loss 
more than this is considered abnormal.  
DYSFUNCTIONAL UTERINE BLEEDING 
 The endometrium responds to various alterations in hormonal balance 
caused due to deficiency of hormone, absence of hormone or excessive hormonal 
secretion. Alteration in the hormone status occurs either due to intrinsic ovarian 
abnormalities (primary) or the hypothalamo- pituitary–ovarian axis disturbances 
(secondary). These hormonal changes brings about arrest in maturation of follicles 
at different stages resulting in morphological changes. This corresponds to the 
maturation stage at which the follicles become impaired. Arrest of follicular 
maturation leads to lack of stimulation of endometrium when the insult occurs 
during the hormone secreting stages of follicle or corpus luteum. When the insult 
results in arrest of follicular regression leading to anovulation or preventing the 
corpus luteal involution the endometrium will be in the state of 
hyperstimulation7,8. 
 Hormonal imbalance occurs due to deficiency of one hormone or excessive 
amount of other and normal state of one. This imbalance produces changes in the 
morphology of the endometrium. These changes can be differentiated with 
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additional factors like clinical history, general examination of patient and the 
diagnosis is made with the microscopic examination of endometrial samples.  
Anovulatory disturbances 
 Deficient Proliferation 
 Endometrial atrophy 
 Estrogen Withdrawal bleeding 
 Irregular Proliferation9 
Ovulatory disturbances9 
 a) Deficient Secretory state 
 1. Deficient Secretory state with dissociated delay 
2. Deficient Secretory state with co-ordinated delay 
- Apparent delay 
- True delay 
      b) Progesterone receptor deficiency 
      1. Dysmenorrhoea Membranacea 
 2.  Irregular shedding 
ANOVULATORY DISTURBANCES9 
DEFICIENT PROLIFERATION  
 Due to central hypogonadotrophism or damage to ovary, if a growing 
follicle does not attain maturity, only very little amount of estrogen will be 
produced with two consequences.  
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1. The LH peak will not occur and LH levels remains low because of 
insufficiency of feedback stimulation.This is due to the decreased 
concentration of FSH in the early phase. Thus, ovulation does not take 
place9.  
2. The endometrium will not undergo proliferation in a right manner because 
it is understimulated.Though the concentration of LH is too low to induce 
ovulation, it may cause sporadic luteinization in the sufficient follicle9.  
 Histologically, the endometrial glands and stroma exhibit a distinct growth 
retardation. The glands are straight and narrow. The lining epithelium of the 
glands is low columnar and contains chromatin rich nuclei in single row with scant 
cytoplasm. The content of estrogen receptor is low. Mitotic activity is rare. The 
stromal cells are small, spindled, poorly differentiated and packed densely. The 
general height of the endometrium is moderate, with its slightly irregular surface 
because of growth variations. The regions which are located close to the blood 
supply are slightly more advanced in their proliferation. This picture remains 
constant throughout the period of menstrual cycle with little variations. 
Occasional subnuclear vacuoles may be found indicating focal abortive secretion 
induced by very little amount of progesterone that are produced in luteinized 
regions of the insufficient follicle9.  
IRREGULAR PROLIFERATION: 
 Although a follicle matures normally, ovulation may not take place either 
because of a defect in LH stimulation or FSH hyperstimulation or because of the 
ovarian damage. The persistent unruptured follicle will continue in estrogen 
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production beyond the proliferation phase for a varying number of days. Then it 
slowly regresses resulting in anovulatory shedding.This may occur at the same 
time of menstrual shedding or may be more or less delayed in onset depending 
upon persistence of the follicle. Irregular proliferation also develops when 
previous repeated anovulatory cycles have built up a relative estrogen 
predominance that increases with each successive anovulatory cycle.  
 Histologically, the growth of the glands and stroma is greater than that of 
the normal proliferative phase. The glands vary in their distribution.They appear 
either closely packed or widely dispersed and there is difference in their diameters. 
Some may be lined by a pseudostratified or even stratified tall columnar epithelial 
cells. On immunohistochemical staining, the nuclei of proliferating epithelial cell 
exhibit strong positivity for estrogen receptors. The stroma is irregularly 
edematous and is composed of densely packed spindle cells. The spiral arteriole 
remains underdeveloped. Instead thin walled venules appear. Although there is 
variation in the height of the endometrium, it is usually markedly increased9. 
 
Figure 14 – Irregular proliferation of endometrium 
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 If the ovulation occurs, the basal vacuoles are seen in the highly 
proliferating glands which lie close to the blood supply. In such cases, a delayed 
and deficient secretion occurs that is never developed as fully as in a normal 
menstrual cycle. In instance, sporadic luteinisation occurs in part of the granulosa 
cells of the persistent unruptured follicle in a similar manner as in the insufficient 
follicle. These luteinized cells also produce little amount of progesterone which 
can induce abortive secretion with the appearance of small basal vacuoles in the 
glandular epithelium. These can be differentiated from those of a truly delayed 
ovulation by their scanty number and small size. If there is unopposed stimulation 
of estrogen, then the irregular proliferation gradually progresses to atypical 
hyperplasia or to a simple (Cystic) glandular hyperplasia9. 
ENDOMETRIAL ATROPHY  
During the reproductive age, atrophy of endometrium is always abnormal 
and it indicates a complete absence of response of endometrium to the ovarian 
hormones. This may be caused either by primary absence or surgical resection of 
ovaries or chemical toxins causing severe damage to the hypothalamic pituitary 
centre or by the local refractoriness of the endometrium to the ovarian hormones. 
The endometrial refractoriness is usually associated with normal ovarian function 
and a regular biphasic menstrual cycle (Plotz, 1950; Eufinger 1952) and is termed 
as the ‘silent ovulation’ of Stieve (1952). This condition is caused due to the 
inability of the cells of the endometrium to produce hormone receptors. If either 
the hormone or the receptor is unavailable, cellular proliferation and 
differentiation does not take place10.  
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Histologically, the epithelial and stromal cells are smaller even at higher 
magnification. Glands resembles capillaries and can hardly be distinguished under 
lower magnification. They are very sparsely distributed and are lined by low 
cuboidal cells with small, round nuclei and dense chromatin. The cytoplasm is 
scant and no mitosis is noted. The stroma is composed of small, densely packed 
spindle cells. The entire height of endometrium is reduced very much and the 
stratum basalis is hard to be recognized. In extreme instances, no glands are noted 
and the flat surface epithelium is separated from the myometrium by a stromal 
layer of few cell thickness. There is minimal blood supply and no spiral arterioles 
are made out. The endometrial atrophy is sometimes associated with the 
development of large dilated venules situated superficially beneath a thin 
endometrium. These venules may rupture sometimes and are probably remains the 
cause of uterine bleeding10. 
 
Figure 15 – Atrophic endometrium 
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OVULATORY DISTURBANCES  
THE DEFICIENT SECRETORY PHASE  
 This entity encompasses a variety of disturbances in the function of corpus 
luteum either of central or ovarian origin with or without preceding abnormal 
follicular development. Some of these syndromes are precisely recognized 
morphologically as they specifically produce changes in the structure of 
endometrium11.  
 The stimulatory effect of progesterone on the endometrium becomes 
deficient when the hormonal balance shift in favour of estrogen the progesterone 
deficiency can be absolute when the production or secretion of progesterone is 
suppressed or relative when hyperestrogenism develops. An absolute 
progesterone deficiency may occur after normal ovulation if the corpus luteum 
fails to develop normally or regress too quickly because of a central or ovarian 
defect such as inadequate luteinization of the granulosa cells or by suppression of 
progesterone release by elevated prolactin levels (Tubert, 1978) or an ovarian 
defect in the ability to induce follicular development (Fox & Buckley, 1982).  
 A relative progesterone deficiency may follow a preceeding follicular 
persistence with delayed ovulation. The associated secretory phase is of normal 
duration or may show an early breakdown. In other instances, the corpus luteal 
insufficiency is preceded by an impaired development of follicle with inadequate 
stimulation of the granulosa cells which may be caused by insufficient secretion 
of FSH in the early follicular phase. In these circumstances, progesterone could 
not fully act on the deficiently proliferated endometrium. Further, the luteal phase 
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is not only deficient but truly or apparently shortened (Strott et al, 1970, Jones, 
1973 and 1975, and Sherman and Korenman, 1974). An apparently luteal phase 
of short duration may result from early ovulation after a phase of short and 
deficient proliferation. On the other hand, the secretory phase may either be truly 
delayed after normal ovulation or apparently delayed following delay in 
ovulation11.  
 In most of the conditions, the concentration of plasma progesterone are low 
during the luteal phase (Moszkowski et al 1962, Abraham et al, 1974). Rarely a 
defect of progesterone receptors in the endometrium may be the cause for a 
relative deficiency of progesterone in the presence of a normal functioning corpus 
luteum (Laatikainen et al, 1983). Proper and correct evaluation of the patient 
requires endometrial biopsy from at least two consecutive cycles (Jones et al, 
1974). On the application of strict criteria, a deficient secretory phase due to 
endogenous disturbances appears to be more common than the previously 
assumed one although Israel in 1959 reported it in only 3.5% of his infertile patient 
and Sillo – Seidle and Dallenbach – Hellweg in 1974 found it in the 20% of their 
infertile patients. The deficient secretory phase is divided into two types, each with 
different cause (Gigon et al, 1970)  
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Figure 16 - DEFICIENT SECRETORY PHASE 
PROGESTERONE RECEPTOR DEFICIENCY  
 A deficient secretory phase is found in women with a normally functioning 
corpus luteum and a properly timed ovulation (Laatikainen et al, 1983 loc cit and 
Spirtos et al, 1985). These patients have progesterone receptors deficiency and 
consequently not only endogenous progesterone (Cooke et al, 1972), but also 
progesterone therapy has null effect on the endometrium. 
ENDOMETRIAL HYPERPLASIA (STANLEY J. ROBBOY ET AL) 
 The endometrial hyperplasia is a heterogeneous group of disorders of 
proliferation. A confusing multiplicity of descriptive terms and a variety of  
largely unsatisfactory classification system hinder a full understanding of the 
nature of hyperplasia. The hallmark of hyperplasia is an increased glandular to 
stromal ratio with associated architectural and sometimes cytological changes11.  
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 The International Society of Gynecological Pathologists (ISGP) and the 
World Health Organization (WHO) proposed a classification scheme in which 
architectural and cytological features are evaluated independently and this 
classification is now widely accepted. This classification divides the lesions into 
those that have cytological atypia and those that do not, the architectural pattern, 
which is simple or complex is of secondary importance11. 
W.H.O. CLASSIFICATION OF ENDOMETRIAL HYPERPLASIA 
Endometrial Hyperplasia 
 Simple 
 Complex (adenomatous) 
Atypical Endometrial Hyperplasia 
 Simple 
 Complex (adenomatous) 
ETIOLOGY 
 Endometrial hyperplasia occurs as a result of excessive stimulation by 
estrogens.  
HISTOLOGICAL FEATURES OF SIMPLE HYERPLASIA 
General  
Increased gland:stroma ratio (greater than 1:1) 
Diffuse changes throughout endometrium 
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Glands 
Architectural features  
 Variation in size and shape of glands 
 Small to large and cystically dilated 
 Minimal and focal crowding 
 Minimal branching with outpouchings and infoldings  
 No complex angularity 
Cellular features 
 Abundant and cellular epithelium 
 Ciliated cell change common 
 Pseudostratification 
Nuclear features 
 Oval and elongated 
 No significant variation in size or shape 
 Evenly dispersed chromatin 
 Small, inconspicuous nucleoli 
 Variable mitotic activity 
Stroma 
 Abundant and cellular 
 Small, oval cells with scanty cytoplasm 
 Mitotic activity in stroma 
 Prominent superficial venules 
 Inconspicuous spiral arterioles11 
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Figure 17 – Simple hyperplasia without atypia 
HISTOLOGICAL FEATURES OF COMPLEX HYPERPLASIA11 
General 
 Focal to extensive 
 Greatly increased gland:stroma ratio (greater than 3:1) 
Glands 
Architectural features 
 Marked variation in size and shape 
 Marked crowding 
 Branching with papillary infoldings and outpouchings(budding) 
 Complex angularity 
Cellular features 
 Abundant and cellular epithelium 
 Ciliated cell change (less than in simple hyperplasia) 
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 Squamous change 
 Pseudostratification 
Nuclear features 
 Oval and elongated 
 No significant variation in size or shape 
 Evenly dispersed chromatin 
 Small, inconspicuous nucleoli 
 Variable mitotic activity 
Stroma 
 Scanty and inconspicuous 
 Dense and cellular 
 
Figure 18- Complex hyperplasia without atypia 
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HISTOLOGICAL FEATURES OF SIMPLE ATYPICAL HYPERPLASIA 
General 11 
 Architectural changes are diffuse throughout endometrium 
 Cellular changes are focal to diffuse 
 Increased gland:stroma ratio (greater than 1:1) 
Glands 
 Architectural features 
 Variation in size and shape 
 Small to large and cystically dilated 
 Minimal and focal crowding 
 Minimal branching with infoldings and outpouchings 
 No complex angularity 
Cellular features 
 Abundant and cellular epithelium 
 Ciliated cell change common 
 Pseudostratification 
 Dense eosinophilia 
Nuclear features 
 Elliptical to round 
 Variation in shape and size 
 Hyperchromasia 
 Nucleoli - prominent, enlarged and irregular 
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 Coarse clumping of chromatin 
 Vesicular nucleus hypochromasia 
 Variable mitotic activity 
Stroma 
 Abundant and cellular 
 Small, oval cells with scanty cytoplasm 
 Mitotic activity in stroma 
 Prominent superficial venules 
 Inconspicuous spiral arterioles 
 
Figure 19 – Simple hyperplasia with atypia 
HISTOLOGICAL FEATURES OF COMPLEX ATYPICAL 
HYPERPLASIA11 
General 
 Focal to extensive  
 Greatly increased gland:stroma ratio(greater than 3:1) 
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Glands 
Architectural features 
 Marked variation in size and shape 
 Marked crowding 
 Branching with papillary infoldings and outpouchings 
 Complex angularity 
Cellular features 
 Abundant and cellular epithelium 
 Ciliated cell change (less than in simple hyperplasia) 
 Squamous change 
 Pseudostratification 
 Dense eosinophilia 
Nuclear features 
 Elliptical to round 
 Variation in shape 
 Variation in size 
 Hyperchromasia 
 Nucleoli prominent, enlarged and irregular 
 Coarse clumping of chromatin 
 Vesicular nucleushyperchromasia 
 Variable mitotic activity 
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Stroma 
 Scanty and inconspicuous 
 Dense and cellular11 
 
Figure 20 – Complex hyperplasia with atypia 
LEIOMYOMA (FIBROID) 
Leiomyoma is the most common tumor of uterus and that of female pelvis. 
It is the most common cause of hysterectomy worldwide. 52 percentage autopsy 
studies have shown that approximately 20% woman over 30 years of age harbor 
uterine myomas of various sizes (Novak et al)   
Leiomyoma is the benign tumor composed mainly of smooth muscle cells 
but also contains varying amounts of fibrous tissue11-18. 
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INCIDENCE 
It is difficult to determine the exact incidence of these tumors. They 
represent 20-30% in the women over 30 years of age, rising to more than 40% in 
those over 40 years of age 12.  
AGE 
 Leiomyoma occur commonly in women during the period of mid 
reproductive years. They have also been reported on rare occasion in young girls 
(augensen-1818). Premenopausal women showed an average number of myoma 
which is three times higher than in case of post menopausal women12-18 
RISK FACTORS 
Age: As age of menarche decreases, there is an increased incidence of leiomyoma. 
Post menopausal women have a 70-90% decreased risk  
Child bearing: Women having a live born child have a 20-50% decrease in risk. 
This reduction in risk gradually increases with number of children born. However, 
the protection offered by childbirth is only temporary because the risk increases 
when the time for her most recent child birth is increased (Telinde et al) 
Exogenous hormones: Exogenous hormones like unopposed estrogen with 
progestins show an increase in the risk 12-16  
Family history: Positive family history increases the risk upto 3.5 fold 12 
Race:There is 9 fold increase in incidence of leiomyoma among black women 
(North American clinics) 
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Diet and other factors: Obesity increases the risk of incidence of fibroids, while 
cigarette smoking is associated with reduced risk (Parassiini F et al 1988). Myoma 
is associated with consumption of beef where as high intake of green vegetable 
seems to have a protective effect (Chiaffasino F etal 1999). Low physical activity, 
high mental stress were one of the risk factors in the etiology and pathogenesis of 
this disease. 
ETIOLOGY 
Uterine leiomyoma was first believed to be purely a local growth due to the 
local reason. But by the end of 19th century, it was accepted that myoma of the 
uterus was related to hormonal disturbances13. In 1935, Witherspoon described 3 
pathological changes that were etiologically closely related. 
1. Myoma of Uterus. 
2. Microcystic degeneration of ovary with incomplete leutinization. 
3. Cystic glandular hyperplasia of the endometrium (J clinic path 1970).  
It is said that hormones especially estrogen, growth hormones and 
progesterone play a vital role in the development and maintenance of uterine 
leiomyoma. Faber et al in 1972 and Tamaya et al in 1978 found that the smooth 
muscle cells are sometimes increased in woman with leiomyoma in their study. In 
1980, Muram et al found that evidence of hormonal dependence includes the 
increased frequency of leiomyoma after menarche and growth of leiomyoma 
during pregnancy12-18. 
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SITES OF OCCURRENCE 
1. Uterine corpus (commonest) 
2. Cervix 
3. Broad ligament 
4. Along other pelvis ligament. 
5. Parasitic 
6. Ovary (Tsalacopouls H et al 1981) 
Within the uterus tumors can be  
1. Intramural-75% 
2. Subserosal-10% 
3. Submucosal-15% (Shaw et al) 
 
Figure 21- Sites of fibroid 
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CLINICAL FEATURES (Telinde et al) 
Abnormal menstruation is the common clinical picture12. 
One third (30%) of patient present with menstrual complaints.  
This can be in the form of  
1. Menorrhagia 
2. Metrorrhagia 
3. Polymenorrhoea 
4. Dysmenorrhoea or combination of these 
PRESSURE SYMPTOMS 
 This is the second most common clinical presentation. These symptoms are 
mainly due to the pressure effect of the leiomyoma on the surrounding structures. 
They may present in the form of difficulty and frequency in micturition, 
constipation, low back ache or pain and discomfort in the lower abdomen. 
Importantly, 30% of the patients come to us with complaints of pain12-18. 
MASS ABDOMEN 
 Few of the patients may present with the complaints of only mass 
abdomen12-18. 
REPRODUCTIVE FAILURE 
 It must be remembered that sometimes fibroids remains the cause of 
infertility or recurrent pregnancy loss 12-18. But it is rare (5%)  
 Symptoms produced by leiomyoma are dependent on the location of the 
tumor within uterus 
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Location Menstrual Pain Integrity Bulk 
Intracavitary + + + - 
Submucosal + + + - 
Intramural + + + - 
Subserosal - + - + 
Pedunculated    - + - + 
    
LEIOMYOMA -VARIANTS 12-18 
 Ceullar leiomyoma 
 Haemorrhagic cellular leiomyoma 
 Epithelioid leiomyoma  
 Symplastic leiomyoma   
 Myxoid leiomyoma 
 Leiomyoma with heterologous element  
LEIOMYOMA - UNUSUAL GROWTH PATTERN 
 Diffuse leiomyomatosis 
 Intravascular leiomyoma 
 Benign leiomyoma 
 Differentiated peritoneal leiomyoma 
GROSS 
        Leiomyoma are solid and white most frequently. They have a whorled 
appearance on cut surface. Ackerman et al in 1990 found that 84% of leiomyoma 
were multicentric12-18. 
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Figure 22 – Gross of leiomyoma 
MICROSCOPIC FEATURES  
Leiomyoma is composed of interlacing fasicles and bundles of smooth 
muscle cells. The smooth muscle cells are markedly elongated having eosinophilic 
cytoplasm and elongated cigar shaped muscle. In an uncomplicated cases, it’s 
nuclei are uniform and mitotic figures absent or sparse. Abdundant reticulin is 
present12-18. 
 
Figure 23 – Microscopy of leiomyoma 
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DEGENERATIVE CHANGES 
Punnonem in 1965 and Arjoon in 1970 found that most forms of 
degenerations occurs as a result of replacement of muscle fibres by hyaline, 
collagen, blood, calcium, mucopolysaccharide or combination of these in their 
studies. 
In 1964, Guptha and Hunter found that cells are admixed with smooth 
muscle cells in leiomyoma. In 1972, Christopher et al reported cellular leiomyoma 
to be more common in older women with uterine atrophy. In the same study, they 
also reported on symplastic leiomyoma. These are nothing but benign smooth 
muscle tumor of uterus which contain large bizarre cells with large nucleus. 
Mitotic count is less than 2/10 HPF. In 1972, Willamson E.O and Christopherson 
reported that leiomyoma arising near serosa especially with pedicle may take up 
the blood supply from the nearby organs and get detached themselves. These are 
called as parasitic leiomyoma12-18. 
       In 1977, Gasser and young reported neurilemmoma like leiomyoma in their 
studies. Sometimes leiomyoma resembles neurilemmoma due to stromal 
hyalinization. They usually demonstrate smooth muscle differentiation ultra 
structurally. In 1980, Mazur and Kraus reported tubular differentiation in 
otherwise characteristic leiomyoma. In 1991, Hu.John Surti et al found that 
cytogenetic alterations are common in uterine leiomyoma. The most common are 
rearrangements of 6p del7qt12 and t12 (12:14)12-18.  
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      Mason tc et al. in 2002 found red degeneration of leiomyoma masquerating 
as retained products of conception. The incidence of leiomyoma in pregnancy is 
approximately 1%. Their presence has been linked to spontaneous abortion, 
fetopelvic disproportion, malposition of fetus, premature labor, soft tissue 
dystocia, uterine inertia, post partum haemorrhage and retention of placenta. 
Discovering calcified uterine myomas is not frequent. Three cases of 
uterine myoma are reported as cause of pelvic calcification and to establish 
differential diagnosis with bladder stones12-19. Diagnosis is made by radiological 
studies in postmenopausal patients (Hermida Perez et al 2003) 
UTERINE PROLAPSE AND LEIOMYOMA  
 In 2004, Mittak Y et al study investigated the frequency and 
implications of incidental findings in uteri which are removed for clinical picture 
of prolapse. They found a high frequency of incidental findings12. 
LEIOMYOMA OF UTERUS AND ASSOCIATED CONDITIONS 
LEIOMYOMA OF UTERUS CORRELATION WITH CYCLICAL 
CHANGES IN ENDOMETRIUM 
 The endometrium undergoes primarily histophysiological and age-related 
changes in the presence of leiomyoma. (Zheleznov BI et al 1990).Endometrial 
structures were normal in 54% of 178 myoma patient and phases of incomplete 
secretion were recorded in 14.6% (Zentral BI et al gynakol 1982, Landecho wshij 
JD et al 1982). 
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LEIOMYOMA AND ENDOMETRIAL THICKNESS 
L.Deligdish et al study of endometrium with myoma, atrophic 
endometrium were the most constant morphological changes in the presence of 
uterine mainly submucous myoma (83%). Atrophy may result not only from 
mechanical pressure but also from postmenpausal hormonal insufficiency 12. The 
myometrial tumor is large and the overlying endometrium may be thinned out. 
LEIOMYOMA AND ENDOMETRIAL HYPERPLASIA 
According to Block et al (1961) the association between uterine myoma 
and endometrial hyperplasia varied between 6% and 80%. Goranjon, Ganotti et al 
(1961) found high oestrogen levels in woman with uterine fibroid and believed 
that the endometrium played a vital role in the synthesis of estrogens. 
Hyperplasia is the most common change seen in the endometrium 
associated with fibroid uterus. (Acta Obs. Gynae. 1963).Teleman S et al (2003) 
studied 390 specimens of hysterectomy. 316 cases presented with different 
degrees of endometrial hyperplasia associated with leiomyoma. Leiomyoma and 
endometrial hyperplasia development is a hormonal context. The most frequent 
type is simple hyperplasia suggesting a rare progression to the highest grades12-18.  
The authors analysed 600 patients with uterine leiomyoma from 
hysterectomy which were performed for the conditions when leiomyoma were 
also studied for control purpose. Major conditions are endometrial hyperplasia. 
(Szajnbok et al 1990) 
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 Biopsy specimens of the endometrium are obtained from the 154 cases 
diagnosed. It showed functional uterine bleeding has the higher incidence 
followed by myoma of the uterus.  
Endometrium in association with myoma shows a little or no departure 
from the normal and the histological sequence of cyclic changes may occur just 
as it does in the ovulatory cycle of non-myomatous patient. On the other hand, in 
considerable proportion of case he finds an association of non ovulatory type of 
cycle with myoma with frequently a hyperplasia of the endometrium of more or 
less marked degree.Endometrial hyperplasia was recordable primary from patient 
with menopausal ovarian dysfunction in patient with uterine myoma (Lond et al, 
1982). 
In 103 out of 786 patients with hyperplasia, myomatous changes were 
noted. This finding correlated with hyperestrogenism, which is usually present in 
both disorders (Todorovic N et al, 2002).  
ADENOMYOSIS 
Adenomyosis of the uterus is a condition which is characterized by a 
benign invasion of the endometrium into the uterine musculature and is associated 
with diffuse overgrowth of uterus20-28.Adenomyosis is found in 25 to 40 % of all 
hysterectomy specimens by Bird and associates. (Bird C et al 1972). 
In adenomyosis, the uterus may be slightly or markedly enlarged though 
the increase in size never reaches large that is seen so often with myoma20-28. 
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However, it must be remembered that adenomyosis and myoma often co exist, the 
myoma being responsible for the frequently large size of the uterus in such cases33. 
 
Figure 24 – Gross of adenomyosis 
Adenomyosis results grossly in an enlarged and bulky uterus because of 
the myometrial hypertrophy that regularly accompanies it.On cut section, the 
diagnosis may be suspected by the presence of depressed small cystic lesions in 
obvious but ill defined bulging zone of muscle hypertrophy20-28. The cause of 
endometrial and muscle growth is the estrogenic hormone secreted by the ovary 
lending the support to the belief that adenomyosis will be found to be considered 
as an endocrine dysfunction of the ovary 28,40 
 
Figure 25 – Microscopy of adenomyosis 
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LEIOMYOMA AND ADENOMYOSIS 
Uterine fibroma is associated in 62% of cases in Ben Aissia N et al study 
of analysis of 35 cases of adenomyosis, (Tunis med.2001). Adenomyosis is more 
frequently associated with leiomyoma but essential adenomyosis was diagnosed 
most constantly when uterine enlargement was noted during menstrual period. 
(Thomas TS Jr et al 1989). 
Adenomyosis was noted in 16% of 2, 616 consecutive hysterctomy 
specimens which were examined during a period of 7 year. Multiparous women 
between the ages 30 and 50 years were most commonly affected37. Abnormal 
uterine bleeding was the common symptom. Myohyperplasia, leiomyoma were 
usually associated lesion. It is seen equally in women of Africa, India and mixed 
races in the West Indian population (Raju GC et al 1988) 
LEIOMYOMA AND ENDOMETRIAL CARCINOMA 
There are a few reported cases of endometrial carcinoma in association 
with leiomyoma. The percentage varies 0.2 to 16.2% (Dupantier N et al 2003, 
Tatamizawa S et al 1999, Studzinki Z et al 2000, Cabrerce J et al 1994, Studzinski 
et al 1998). According to Zhonghua L et al 1990, there is no association of 
endometrial carcinoma and leiomyoma27.  
 
 
 
  
 
  
 
Materials & 
Methods 
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 MATERIALS AND METHODS 
AIM OF STUDY 
 To study the changes of endometrium in association with myometrial 
lesions of hysterectomy specimens with respect to various clinical and 
morphological features. 
OBJECTIVES OF THE STUDY 
 To analyse the histopathological changes of endometrium in association 
with myometrial lesions of hysterectomy specimens in our Institution with respect 
to LMP and age.  
 To assess the age distribution of the myometrial lesions in patients 
subjected to hysterectomy.  
    To assess the endometrial changes in relation with the types and sites of 
myometrial lesions in hysterectomy specimens. 
Type of study : Analytical Study 
Place of study : Department of Pathology, TSRMMCH & RC, Trichy. 
Sample size : 250 cases 
Study design : Descriptive (Prospective and Retrospective ) study 
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INCLUSION CRITERIA  
 Patients undergoing hysterectomy for myometrial lesions presenting with 
clinical symptoms.  
EXCLUSION CRITERIA 
 Specimens of endometrial curettage and aspiration.  
 Patients for whom hysterectomy is performed for non-myometrial lesions. 
DATA ANALYSIS : By SPSS(Statistical Package for the Social Sciences) 
Software 
SAMPLE SIZE AND SAMPLING: 
 This was a prospective and retrospective study performed on hysterectomy 
specimens received at the Department of Pathology, Chennai Medical College 
Hospital and Research Centre for a period of one and half years from November 
2016 to June 2018 after getting ethical clearance. A total of 250 cases in all age 
group were included in the study. The endometrial patterns were analyzed in 
hysterectomy specimens with myometrial lesions. 
BRIEF METHODOLGY FOR STUDY DESIGN  
 The endometrium will be studied for the patients who underwent 
hysterectomy for clinical symptoms of myometrial lesions. 10% buffered formalin 
will be used for fixation of specimens.  
 A total of 250 hysterectomy specimens with myometrial lesions are taken. 
A detailed gross examination was performed with respect to location and size of 
59 
leiomyoma, and status of endometrium and endometrial polyp if any was 
noted.Tissue bits from representative areas of the leiomyoma and endometrium 
were taken for histopathological examination, processed and paraffin blocks were 
made. Sections were cut at 5-micron thickness and stained with hematoxylin and 
eosin. Microscopic sections were studied and following histologic features were 
recorded: 
Endometrial parameters - endometrium, phase, appearance of glands and 
stromal changes. 
Myometrial parameters- presence or absence of adenomyosis, type or variant of 
leiomyoma. 
HEMATOXYLIN AND EOSIN STAIN PROCEDURE 
1. Deparafffinise the tissue sections in xylene for 5-10 mins. 
2. Subject the tissue section to water through reducing grades of 
alcohol.(100% - 50%) 
3. Keep it in hematoxylin for15 to 20 mins. 
4. Rinse in tap water. 
5. Differentiate with 1%acid alcohol. 
6. For bluing – place in tap water for about 10 mins. 
7. Counterstain by eosin 1-2mins. 
8. Rinse in water. 
9. Dehydration followed by clearing and mounting it. 
  
  
 
 
  
 
Observation                      
& Results 
60 
OBSERVATION  AND RESULTS 
Table 1 - AGE DESCRIPTION OF THE PATIENTS 
Minimum Maximum Mean Std. Deviation 
   32           67 44.61 5.96 
 
Comments: 
The mean age of the patients was 44.61 ± 5.96 years.  
The minimum and maximum age of the patients was 32 and 67 years respectively. 
Table 2 - AGE WISE DISTRIBUTION OF PATIENTS 
Comments: 
 Out of 250 patients, 68% (170) patients were from the age group 40 to 49 
years. It was followed by patients from 30 - 39 years, 16% (40) and 50 - 59 years, 
13.2% (33). The least number of patients were from the age group 60 - 69 years, 
2.8% (7). 
 
 
Age in years No. of cases Percent 
30-39 40 16.0 
40-49 170 68.0 
50-59 33 13.2 
60-69 7 2.8 
TOTAL 250 100 
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Graph 1 - Distribution of patients according to age group 
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Table 3 – Distribution of endometrial changes according to age group 
ENDOMETRIA
L CHANGES 
AGE RANGE IN YEARS 
30 - 39 40 - 49 50 - 59 60 – 69 
F P F P F P F P 
PP 10 25.0 39 22.9 3 9.1     
ES 16 40.0 51 30.0 8 24.2     
LS 5 12.5 33 19.4 2 6.1     
DPP 3 7.5 22 12.9 2 6.1     
SH 6 15.0 18 10.6 4 12.1     
CH     1 .6         
Atrophic     5 2.9 13 39.4 6 85.7 
EIN     1 .6         
EC         1 3.0     
Others             1 14.3 
TOTAL 40 100.0 170 100.0 33 100.0 7 100.0 
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Graph 2 - Endometrial changes according to the age group 
 
 
 
 
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
30 -39 40 - 49 50 - 59 60 -69
P
e
rc
e
n
ta
ge
Age group in years
PP ES LS DPP SH CH Atrophic EIN EC Others
64 
Table 4 - DISTRIBUTION OF LEIOMYOMA BASED ON LOCATION IN 
UTERUS 
 
 
 
 
 
 
 
 
 
Comments: 
 Most number of leiomyomas were located intramurally 52.8% (132). It was 
followed by submucous [14.4% (36)] and intramural and submucous combination 
[10% (25)] location. The number of cases with subserous and combination of 
intramucous and subserous was 9.2% (23) and 8% (20) respectively. Least number 
of cases were located in submucous and subserous combination [2.4% (6)] and 
intramural, subserous, submucous combination [3, 2% (8)] 
  
S.No. Location Frequency Percent 
1 Intra mural 132 52.8 
2 Sub mucous 36 14.4 
3 Sub serous 23 9.2 
4 Intra mural and Sub mucous 25 10.0 
5 Intramural and Subserous 20 8.0 
6 Sub mucous and Sub serous 6 2.4 
7 
Intramural, Submucous and 
Subserous 
8 3.2 
TOTAL 250 100.0 
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Graph 3 - Distribution of Leiomyoma according to site 
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Table 5 - DISTRIBUTION OF LEIOMYOMA OF UTERUS BASED ON 
NUMBER 
 
Number Frequency Percent 
Single 173 69.2 
Multiple 77 30.8 
TOTAL 250 100.0 
Comments: 
 Majority of the cases reported were single [69.2% (173)]. Totally 77 cases 
(30.8%) reported were multiple in number. 
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Graph 4 - Distribution of Leiomyoma according to number 
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Table 6 - DISTRIBUTION OF ENDOMETRIAL CHANGES IN LEIOMYOMA 
Comments: 
 Thirty percent (75) of the cases reported was associated with early 
secretoryphase. The percent of cases associated with proliferative phase and late 
secretory phases were 20.8% (52) and 16% (40) respectively. The percent of cases 
associated with simple hyperplasia, disordered proliferative phase and atrophic 
endometrium were 11.2% (28), 10.8% (27) and 9.6% (24) respectively. There was 
one (0.4%, totally 2%) case of each - complex hyperplasia, Endometrial 
intraepithelial invasion, endometrial carcinoma and other. 
    
S.No. Endometrial Change Frequency Percent 
1 Proliferative Phase 52 20.8 
2 Early Secretory Phase 75 30 
3 Late Secretory Phase 40 16 
4 Disordered proliferative phase 27 10.8 
5 Simple Hyperplasia 28 11.2 
6 Complex Hyperplasia 1 0.4 
7 Atrophic Endometrium 24 9.6 
8 
Endometrial intraepithelial 
neoplasia 
1 0.4 
9 Endometrial carcinoma 1 0.4 
10 Others 1 0.4 
  TOTAL 250 100.0 
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Graph 5 - Distribution of endometrial changes in leiomyoma 
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Table 7 – Distribution of endometrial changes according to the site of leiomyoma 
 
 
ENDOMETRIAL 
CHANGES 
LOCATION OF LEIOMYOMA 
IM SM SS IM + SM IM + SS SM + SS IM + SM + SS 
F P F P F P F P F P F P F P 
PP 23 17.4 10 27.8 3 13.0 7 28.0 4 20.0 4 66.7 1 12.5 
ES 43 32.6 9 25.0 9 39.1 3 12.0 7 35.0     4 50.0 
LS 23 17.4 7 19.4 3 13.0 3 12.0 2 10.0 2 33.3     
DPP 13 9.8 1 2.8 2 8.7 6 24.0 3 15.0     2 25.0 
SH 15 11.4 4 11.1 1 4.3 5 20.0 2 10.0     1 12.5 
CH 1 .8                         
Atrophic 12 9.1 5 13.9 4 17.4 1 4.0 2 10.0         
EIN 1 .8                         
EC 1 .8                         
Others         1 4.3                 
TOTAL 132 100.0 36 100.0 23 100.0 25 100.0 20 100.0 6 100.0 8 100.0 
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Graph 5 – Distribution of endometrial changes according to the site of  
leiomyoma 
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Table 8 - DISTRIBUTION OF LEIOMYOMA ACCORDING TO LMP 
LMP in days Frequency Percent 
< 7 days 7 2.8 
7 to 15 days 55 22.0 
16 to 30 days 97 38.8 
> 30 days 59 23.6 
Post menopausal 32 12.8 
TOTAL 250 100.0 
 
Comments: 
 Majority of the leiomyoma cases 38.8% (97) had LMP of 16 to 30 days. It 
was followed by LMP of greater than 30 days [23.6% (59)] and 7 to 15 days [22% 
(55)]. Only 2.8% (7) were associated with LMP of less than seven days. 
Leiomyomas associated with post menopause were 12.8% (32) 
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Graph 7 - Distribution of Leiomyoma according to LMP 
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Table 9 – Distribution of endometrial changes according to LMP 
ENDOMETRIAL 
CHANGES 
LMP IN DAYS 
<7 7 - 15 16 - 30 >30 Post menopausal 
F P F P F P F P F P 
PP 2 28.6 20 36.4 17 17.5 7 11.9 6 18.8 
ES 3 42.9 19 34.5 41 42.3 11 18.6 1 3.1 
LS     2 3.6 12 12.4 26 44.1     
DPP 1 14.3 6 10.9 13 13.4 6 10.2 1 3.1 
SH 1 14.3 7 12.7 10 10.3 8 13.6 2 6.3 
CH             1 1.7     
Atrophic     1 1.8 3 3.1     20 62.5 
EIN         1 1.0         
EC         97 100.0     1 3.1 
Others                 1 3.1 
TOTAL 7 100.0 55 100.0 97 100.0 59 100.0 32 100.0 
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Graph 8 – Distribution of Endometrial changes according to the LMP 
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Table 10 - DISTRIBUTION OF ADENOMYOSIS IN LEIOMYOMA CASES 
 
Comments: 
 Adenomyosis was present in 42.4% (106) of leiomyoma cases.  
 
 
 
 
 
 
 
 
Lesion Frequency Percent 
None 144 57.6 
Adenomyosis 106 42.4 
TOTAL 250 100.0 
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Graph 9- Distribution of adenomyosis in leiomyoma cases 
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COLOR PLATES 
 
Figure i – H4483/16 – Submucous leiomyoma 
 
 
Figure ii – H4178/16 – Endometrial carcinoma 
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Figure iii -CLASSICAL LEIOMYOMA. (H&E4X) (H476/17) 
 
 
Figure iv - LEIOMYOMA SHOWING SPINDLE CELLS. (H&E10X) 
(H4296/17) 
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Figure v - LEIOMYOMA SHOWING NUCLEI WITH BLUNTED TIPS. 
(H&E 40X) (H4096/17) 
 
 
 
Figure vi- ADENOMYOSIS (H2807/16) 
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Figure vii - PROLIFERTIVE ENDOMETRIUM (H2732/16) 
 
 
 
Figure viii - SECRETORY ENDOMETRIUM SHOWING SUBNUCLEAR 
VACUOLATION (H2484/16) 
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Figure ix - SIMPLE HYPERPLASIA WITHOUT ATYPIA OF 
ENDOMETRIUM (H3054/16) 
 
 
Figure x - COMPLEX HYPERPLASIA WITHOUT ATYPIA OF 
ENDOMETRIUM (H1270/17) 
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Figure xi - ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA 
(H973/18) 
 
 
 
Figure xii - ENDOMETRIAL CARCINOMA (H4178/16) 
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DISCUSSION 
 Leiomyoma of the uterus is the most common neoplasm. Many of these 
tumours are small and so remain undetected and are often incidental findings. 
Ackerman et al did a meticulous study of 100 consecutive hysterectomy specimen 
of which 77 revealed leiomyomas. Although Ackerman et al reported 84% of 
leiomyomas as multicentric, current study showed an increased incidence of 
single fibroids. Of 250 leiomyomas 69.2% were single and 30.8were multiple. 
This difference needs to be evaluated further. 
 Leiomyoma occurs chiefly in women during active mid reproductive years. 
They are present in 20 to 30% of women over 30 years of age, rising to more than 
40% in those over 40 years old (Malcom. C, Anderson et al). Premenopausal 
patients showed an average number of myoma almost three times higher than post 
menopausal women (Cabrera et al 1994). In current study, only 16% were in the 
age group between 30 to 39 years. In this study most of the cases occurred in 40-
49 age group. Only few cases were seen in post menopausal women age group. 
The reason for this could not be explained by the theory of enhanced estrogen 
stimulation causing uterine fibroids. (Muram et al). This difference needs to be 
further studied. 
 Within the uterus the leiomyoma can be intramural, subserous and 
submucous. Shaw et al noted these were 75%, 10% and 15% in their study 
group.In this study, 52.8% of cases showed intra mural fibroids. 14.4% showed in 
submucous region, 9.2% were subserous location. Both in submucous and 
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intramural region were 10% , intramural and subserous were 8%, submucous and 
subserous were 2.4%, all the three location were 3.2%. This finding goes in hand 
with the reference cited. 
ENDOMETRIAL CHANGES 
 In the current study, thirty percent (75) of the cases reported was associated 
with early secretoryphase. The percent of cases associated with proliferative phase 
and late secretory phases were 20.8% (52) and 16% (40) respectively. The percent 
of cases associated with simple hyperplasia, disordered proliferative phase and 
atrophic endometrium were 11.2% (28), 10.8% (27) and 9.6% (24) respectively. 
There was one (0.4%, totally 2%) case of each - complex hyperplasia, Endometrial 
intraepithelial neoplasia, endometrial carcinoma. 
 Granjone Yanotti and Cedavd (1961) found high estrogen level in women 
with uterine fibroids and believed that endometrium played a role in synthesis of 
estrogen. According to CH Buckley, H Fox et al, these changes are insufficient to 
warrant a diagnosis of hyperplasia but are recognised as prolonged proliferative 
phase in some patients50. Mitotic activity continues beyond the 14th day of the 
cycle. But in this study, 11.2% cases showed simple hyperplasia and only 0.4% 
showed complex hyperplasia. According to Zhleznov BI et al., 1990, in the cases 
of leiomyoma, the endometrium undergoes primarily age related changes and 
histopathological changes. According to Land echowskij JD et al., 1982,. 
endometrial structures were normal in 54% of 178 patients with myoma and 
phases of incomplete secretion were recorded as 14.6%. 
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 If the myometrial tumor is large, the overlying endometrium may be 
thinned out (CH Bukley et al 1989). The atrophic endometrium were the most 
constant morphological change in the presence of submucous leiomyoma (83%). 
Atrophy is not only due to mechanical pressure but also from the hormonal 
insufficiency that occurs in the post menopausal period (L.Deligdish et al Study- 
J. clinic Path 1970). In this study, the current study showed thinned out 
endometrium of 0.1 to 0.2cm in 17.4% of subserosal leiomyoma, 13.9% of the 
submucous leiomyoma cases and in 9.1% of intra mural leiomyoma and very few 
cases of post menopausal women. This should be further evaluated in detail. 
 Bolck et al 1961 reported endometrial hyperplasia varied between 6% and 
80%. Hyperplasia is the most common changes in the endometrium with fibroid 
uterus (Acta Ob.Gynec. 1963). Out of 390 hysterectomy specimens, 316 cases 
presented with leiomyoma with different degrees of endometrial hyperplasia. Both 
leiomyoma and endometrial hyperplasia develop in hormonal context. The most 
frequently occurring type is simple hyperplasia, suggesting that there is a rare 
progression to highest grades.Thus, leiomyoma has a possible protective role as a 
target tissue which captures estrogen (Teleman S et al, 2003). Lattinen (1964) 
reported that hyperplasia was the most common change in the endometrium noted 
in the leiomyoma of uterus (J clin path 1970). In accordance with these studies the 
current study showed 11.2% of simple hyperplasia, 0.4% of Complex hyperplasia. 
These features are due to protective role of uterine leiomyoma.  
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 In the presence of leiomyoma, the endometrium undergoes 
histophysiological as well as age related changes (Zhelezenov Bi et al 1990). 
Hyperplasia of the endometrium was recordable primarily from the women with 
menopausal ovarian dysfunction (Zentrabl gynekol 1982)108. In the current study, 
most of the cases were between 40 to 49 years. Of this age group, simple 
hyperplasia was seen in 10.6%. 22.9% showed proliferative phase. 10.6% showed 
early secretory phase. 40 cases belonged to age more than 50 years. Of these, 19 
cases showed atrophic endometrium and 4 cases showed simple hyperplasia. 
 In 1961, Goranjon et al found the presence of high estrogen levels in 
women with uterine leiomyoma and believed that the endometrium played role in 
the synthesis of these estrogens50. Novak and wood druff (1962) described the 
association between leiomyoma and the an-ovulatory cycle with endometrial 
hyperplasia. However, in some patients, these changes are insufficient to warrant 
a diagnosis of hyperplasia but are recognizable as those of a prolonged 
proliferative phase. Mitotic activity continues beyond the 14th day of cycle (CH 
Bukley et al). In this study, out of 250 cases, 97 cases had LMP of 16 to 30 days 
and 39 cases more than 30 days of LMP.  Out of 250 cases, 30 cases showed 
persistent proliferative phase with LMP more than 15 days. 20 cases out of 250 
cases with Simple Hyperplasia had LMP of more than 15 days. This showed 
unopposed estrogenic action (Hyper estrogenic stage). 20 cases showing atrophic 
endometrium were postmenopausal women. 
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 Adenomyosis was the commonest leiomyoma associated pathology 
observed in the present study with an incidence of 87 (43.50%) out of 200 cases, 
which is comparable to the study conducted by CarterJE, Kong I I108 (23%). 
Comparative percentage of adenomyosis in various studies. 
Author                                     Year Percentage 
Rosario Pinto    1968 11.3 
Carter JE, Kong II 1994 23 
Bazot M et al 2001 33 
Present study  2016 42.4 
 
 The frequency of adenomyosis which was reported in the literatures ranges 
widely from (5- 70%).108There are many reasons for this marked variations but no 
really satisfactory statistics had been found. The selection criteria is accountable 
for the myometrial specimens, and the varying histological criteria for the 
diagnosis of adenomyosis. This contributes to the disparity in estimation. Thus, 
awareness among pathologists in this condition, the number and site of 
myometrial samples analyzed, and the histological criteria used may all have an 
influence on the diagnosis of adenomyosis. 
Association of adenomyosis with leiomyoma: 
 In the present study, leiomyoma associated with adenomyosis was noted in 
22.0 % of cases. It correlates with the observation made by Loffer136 (1989, 16%) 
and comparatively less with other studies. 
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Association of leiomyoma with adenomyosis in different studies 
Author Year Percentage 
Molitor  1971 38.40 
Bird et al 1972 53.00 
Loffer  1989 16.0 
McCausland 1992 55.00 
Present study 2016 42.40 
 
 Adenomyosis in leiomyoma was associated feature seen in the present 
study. 106 out of 250 leiomyomas was associated with adenomyosis forming 25%. 
Raju GC et al (1980) reported 16%, Ben Aissia N et al (2001) had reported 62% 
and Thomas JS et al (1989) had noted more frequent association. Raju GC et al 
study in 1980 noted that association of adenomyosis in leiomyoma was the most 
common feature seen in reproductive period with variations in lmp. The present 
study also, 24% of leiomyoma in the reproductive age group were seen to be 
associated with adenomyosis. The common endometrial change seen is early 
secretory phase. 
 According to Zhonghua L et al 1990, there is no association of endometrial 
carcinoma and leiomyoma. This points to the fact, that there could be protective 
role of leiomyoma on endometrium hypothesized by Teleman S et al 2003. There 
are a few reported cases of endometrial carcinoma in association with leiomyoma. 
The percentage varies 0.2 to 16.2% (Dupantier N et al 2003, Tatamizawa S et al 
1999, Studzinki Z et al 2000, Cabrerce J et al 1994, Studzinski et al 1998). In the 
present study, two cases presented with endometrial carcinoma and one case 
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presented with endometrial intraepithelial carcinoma. The association of 
leiomyoma with endometrial carcinoma should be further evaluated. 
 The incidence of leiomyoma is almost equal to other data available in the 
world literature. Many of the endometrial changes noted also correlated with 
findings of other authors.  
 Many authors worked on the endometrial changes in leiomyoma. A 
comparison with those studies revealed that the current observations were 
corrobarative except for few variations. 
 A striking observation was the association of adenomyosis and fibroid, 
40% uterine leiomyoma was associated with adenomyosis, which substantiates 
the hypothesis of hormonal dependency of this tumours. 
 Persistent proliferative phase and simple hyperplasia were seen beyond 15 
days of LMP. This means all these patients showed hyperestrogenic status, which 
also explains the various menstrual disturbances the patient present with. 
Reproductive failure may also be explained by these changes. 
 Though L Deligish and M Loe observed atrophic endometrium in 83% of 
submucous myoma, which is only a pressure change, there were significant 
number of cases showed proliferative phase, which could only be explained by the 
lower age group affected. 
 One case with endometrial intraepithelial neoplasm and another two cases 
with endometrial carcinoma were observed. There were very few cases reported 
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in the literature which substantiates the hypothesis of protective role of 
leiomyoma. However, the association between leiomyoma and endometrial 
carcinoma should be studied further. 
  
  
 
 
  
 
Summary 
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SUMMARY  
 During the study period between November 2016 to June 2018, 250 
hysterectomy specimens with myometrial lesions( leiomyoma) were taken up for 
studying endometrial changes and their association with adenomyosis. 
1. MYOMETRIAL LESIONS(LEIOMYOMA): 
a) The incidence of leiomyoma was 26.31% 
b) Most of leiomyoma were seen in premenopausal women, of age group 
between 30 to 49 years with an incidence of 84%.Only 16% of were seen 
in postmenopausal age group. 
c) This study showed a higher incidence of unicentric fibroid with an 
incidence of 69.2% 
d) Most of the fibroids were present in intramural location with an incidence 
52.8% followed by submucous fibroid with an incidence of 14.4%. 
2. ENDOMETRIAL CHANGES : 
a) The endometrium was thinned out (0.1 to 0.2cm) in all the submucous 
fibroids (36 cases) intramural fibroids and 20 cases of postmenopausal 
women. 
b) 20.8% showed proliferative phase and 9.6% showed atrophic 
endometrium.28 showed simple hyperplasia that is 11.2%. Complex 
hyperplasia was seen in 0.4%. 
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c) Of 36 submucous leiomyomas, simple hyperplasia was seen in 
11.1%.Proliferative phase was seen in 27.8%. Atrophic endometrium was 
seen in  13.9%. 
d) In this study, 97 cases had LMP of 16 to 30 days and 59 had more than 30 
days of LMP. 
e) 20 cases showed persistent proliferative phase with LMP more than 15 
days.21 cases showed endometrial hyperplasia with LMP of more than 15 
days. 
3. AGE DISTRIBUTION: 
a) Most of the cases were between 40 to 49 years. In this age group, simple 
hyperplasia seen in 10.6%. 22.9% showed proliferative phase. 19.4% 
showed late secretory phase. 
b) Above 50 years age group 40 cases were reported. Of these 19 showed 
atrophic endometrium. 
4. ASSOCIATION WITH ADENOMYOSIS: 
 Adenomyosis was with 106 cases with an incidence of 42.4%.Out of 106 
cases of adenomyosis, 26 cases showed myohyperplasia. 
 Malignant myometrial lesions were not obtained during the period of this 
study.  
 
 
  
 
 
  
 
Conclusion 
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CONCLUSION 
 In this study, most of the myometrial lesions(leiomyoma) were seen in the 
4th and 5th decades of life. Intramural location was seen more than other locations. 
 The endometrial changes seen were thinning hyperplasia(simple as well as 
complex) and infrequently carcinomatous change. The older group of women in 
this study had atrophic endometrium and relative changes. 
 Many of the cases had persistent hyperestrogenic stimulus. 
     Adenomyosis and myohyperplasia were frequent associations. 
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ANNEXURE 
PROFORMA 
• Name                          : 
• Age                             : 
• LMP                           : 
• IP no.                          : 
• Date of collection                : 
• Case history                    : 
• Size of myometrial lesion        : 
• Type of myometrial lesion       : 
– Benign 
• Leiomyoma(subserosal/intramural/submucosal) 
• Adenomyosis  
– Malignant 
• Leiomyosarcoma  
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CONSENT FORM – I 
INTRODUCTION 
 You are invited to take part in a research study conducted by R.RATHIKA 
at TRICHYSRM MEDICAL COLLEGE HOSPITAL AND RESEARCH 
CENTRE. You are invited to participate because of MYOMETRIAL 
LESION.If you take part in this studyyou will be one of the people expected to 
participate in study.This study is conducted under the supervision of the course 
instructor Dr.K.Amedkar raj.No funding has been received for this study. 
PROCEDURES 
 If you agree to participate you will be interviewed about your complaints. 
The interview will last for about 20 – 30 minutes. 
RISKS 
 To the best of our knowledge, participation in this study has no risk or harm 
to you. It is possible that some of the questions will make you uncomfortable but 
you are free to refuse to answer any questions or to stop at any time. 
BENEFITS AND COSTS 
 You do not have to pay to participate in this study. You will not receive 
any direct benefits from participating in this study but we hope to gather 
information that will help us to evaluate the HISTOPATHOLOGICAL 
ANALYSIS OF     ENDOMETRIAL CHANGES IN ASSOCIATION WITH 
MYOMETRIAL LESIONS OF HYSTERECTOMY SPECIMENS. You will 
not be compensated for participating in this study. 
WITHDRAWAL FROM THE STUDY 
 Participation in this is voluntary. You have the right to refuse to take part 
in this study. 
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If you chose to participate you have the right to withdraw at any time without 
penalty or loss of benefits to which otherwise you are entitled. If there are any new 
findings during this study that may affect whether you want to continue to take 
part, you will be told about them as soon as possible. The student researchers may 
decide to discontinue your participation without your permission because they 
may decide that staying in this study will be bad for you or for any other reasons. 
CONFIDENTIALITY 
 Protecting participants confidentiality is of the utmost importance 
throughout this research study. All information obtained in the interview will 
remain confidential. Only the student researcher R.RATHIKA will have access 
to the link between the participant name and study ID which will be stored 
separately AFTER the interview. 
 The information from the interviews will be used for research purpose only. 
Participants identity will not be revealed in any paper resulting from this project. 
QUESTIONS OR PROBLEMS 
 You are encouraged to ask questions now and at any time during this study. 
You can reach Dr.R.Rathika at TRICHY SRM MEDICAL COLLEGE 
HOSPITAL AND RESEARCH CENTRE for any queries. You could be 
contacted by the student researcher if she has any questions about your 
participation in this study. 
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CONSENT FORM - II 
PARTICIPANT CONSENT FORM CERTIFICATION 
 I, Mrs.___________ voluntarily agree for the participation as a subject of 
this research study by signing the consent form. The purpose and details of the 
study has been explained to me in my own vernacular language. I assure that I 
understood the above study and had the opportunity to ask questions. I may 
withdraw from the study anytime. 
I agree not to restrict the data or results that arise from this study provided such a 
use is only for scientific purposes. 
SIGNATURES:                                          DATE: 
1.______________ 
NAME AND SIGNATURE OF THE PARTICIPANT 
2.______________ 
NAME AND SIGNATURE OF THE WITNESS 
 
 
 
  
108 
âU¢á v°.M®.v«. kU¤Jtkid k‰W« MuhŒ¢á ika« 
ïU§fq®, âU¢áuh¥gŸË - 621 105. 
 
x¥òjš got« 
 âU¢á v°.M®.v«. kU¤Jtkid k‰W« MuhŒ¢á ika¤â‹ nehŒ 
F¿Æaš JiwÆš el¤j¥gL« f®g¥ig nehŒfŸ F¿¤j MŒÉš g§nf‰FkhW 
c§fis nf£L¡ bfhŸ»nwh«. 
 ï¥gÇnrhjid¡F r«kâ¥gJ c§fŸ ÉU¥g¤ij¥ bghW¤jJ. 
 ï¢nrhjid¡F f£lz« »ilahJ 
 f£lha« vJî« ïšiy 
 gÇnrhjidÆÈUªJ vªneuK« Éyf j§fS¡F KG cÇik c©L. 
ïªj MŒÉ‹ KoîfŸ kU¤Jt« k‰W« ÉŠPhd K‹nd‰w¤â‰F cjî« v‹W 
fUJ»‹nwh«.  ïitfis ntW vj‰F« ga‹gL¤j¥gl kh£lhJ vd 
cWâaË¡»nwh«. 
x¥òjš 
 eh‹ âU/âUkâ /  bršÉ / …………………………………………………… 
KftÇ . …………………………………………………………………………………. 
ehŸ . . . . . . . . . . . . . . . . . .  m‹W nk‰f©l MŒî¡fhf jftš got¤âid go¤J, 
nf£L òÇªJ bfh©L ïªj MuhŒ¢á¡F mWitá»¢ir _y« v‹id 
gÇnrhjid brŒa mDkâ¡»nw‹. v‹ kd¥ó®tkhd r«kj¤ij mË¥gnjhL 
ïªj MŒÉ‹ Koîfis kU¤Jt« k‰W« ÉŠPhd neh¡f¤â‰F ga‹gL¤j 
x¥òjš mË¡»nw‹. 
 
g§nf‰ghs® ifbah¥g«  MŒths® / r«kj« bgWgt® ifbah¥g« 
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1 Jerina begam 56 H 2461 / 16 1             1   1 PM             1       
2 Dhanalakshmi 35 H 2484 / 16   1           1   1 30   1                 
3 Santhanamary 47 H 2486 / 16         1       1 1 10   1                 
4 Saroja 60 H 2488 / 16     1         1     PM             1       
5 Sivakami 60 H 2502 / 16 1               1   PM             1       
6 Saraswathy 55 H 2577 / 16   1           1   1 PM             1       
7 Muthukannu 48 H 2578 / 16 1             1   1 28       1             
8 Kulanthaiyammal 45 H 2600 / 16         1       1 1 35     1               
9 Banumathi 41 H 2694 / 16     1         1     42     1               
10 Panjavarnam 44 H 2696 / 16 1             1     38     1               
11 Karupayee 47 H 2731 / 16 1             1   1 24       1             
12 Vembu 34 H 2732 / 16         1       1 1 26 1                   
13 Umarani 42 H 2799 / 16     1         1   1 28   1                 
14 Arivumalar 42 H 2806 / 16 1               1   14   1                 
15 Kunjammal 50 H 2807 / 16 1               1   26   1                 
16 Pappathy 62 H 2808 / 16     1         1   1 PM             1       
17 Kasthuri 40 H 2824 / 16         1       1 1 15   1                 
18 Malliga 45 H 2825 / 16 1               1 1 27     1               
19 Jayarani 45 H 2841 / 16     1           1 1 23     1               
20 Kavitha 35 H 2840 / 16 1             1     16 1                   
21 Poongodi 42 H 2910 / 16 1             1     48 1                   
22 Vijaya 45 H 2930 / 16       1       1     22       1             
23 Sudha 34 H 2948 / 16   1           1     18 1                   
24 Jegathambal 41 H 3024 / 16         1       1 1 56     1               
25 Radhakumari 46 H 3040 / 16       1       1     24       1             
26 Parameshwari 48 H 3053 / 16           1   1   1 7 1                   
27 Latha 43 H 3054 / 16 1             1     10         1           
28 Parameshwari 42 H 3055 / 16             1 1     13       1             
29 Lakshmi 42 H 3115 / 16             1 1     14 1                   
30 Pappi 43 H 3116 / 16 1               1 1 12       1             
110 
31 Jothi 36 H 3156 / 16 1             1     19   1                 
32 Senthamil selvi 45 H 3232 / 16       1         1   21         1           
33 Pushpavalli 40 H 3266 / 16 1             1     34     1               
34 Kala 40 H 3378 / 16 1             1     7 1                   
35 jhancy 37 H 3462 / 16       1         1   35       1             
36 Mary 42 H 3480 / 16 1               1 1 8 1                   
37 Lakshmi 45 H 3485 / 16       1         1   44         1           
38 Ambiga 46 H 3540 / 16       1       1     22 1                   
39 Seva 60 H 3563 / 16 1             1   1 PM             1       
40 Selvi 38 H 3565 / 16       1         1   18 1                   
41 Anjalai 45 H 3587 / 16   1           1     7 1                   
42 Mariyayee 41 H 3637 / 16           1     1   10 1                   
43 Rani 52 H 3644 / 16 1             1     PM             1       
44 Rajeswari 32 H 3646 / 16             1   1   23   1                 
45 Shanthi 48 H 3648 / 16 1               1   13 1                   
46 Valarmathy 52 H 3671 / 16   1           1     PM             1       
47 Eshwari 45 H 3086 / 16           1   1     36     1               
48 Anthoniyammal 42 H 3762 / 16             1   1   16       1             
49 Selvi 46 H 3793 / 16   1           1     9 1                   
50 Vasantha 35 H 3795 / 16   1           1   1 46     1               
51 Parvathy 50 H 3829 / 16 1             1   1 PM             1       
52 Vijayalakshmi 45 H 3843 / 16         1     1     23 1                   
53 Tamilarasi 48 H 3845 / 16 1             1     9 1                   
54 Rani 46 H 3859 / 16   1           1   1 8 1                   
55 Lakshmi 49 H 3895 / 16   1           1   1 34     1               
56 Saraswathy 52 H 4061 / 16 1             1   1 28   1                 
57 Vijaya 36 H 4119 / 16 1             1   1 24   1                 
58 Bathurnisha 38 H 4249 / 16 1             1     32         1           
59 Kalaiselvi 52 H 4279 / 16 1             1   1 26   1                 
60 Amudha 46 H 4296 / 16 1             1   1 14 1                   
61 Muthulakshmi 62 H 4178 / 16     1         1     PM                 1   
62 Chinnammal 45 H 4244 / 16 1             1     27   1                 
63 Pappu 52 H 4375 / 16 1             1     32     1               
64 Rajammal 55 H 4450 / 16         1       1 1 PM             1       
65 Umamaheswari 40 H 4411 / 16 1             1     33   1                 
66 Sabiya 48 H 4482 / 16 1             1     40   1                 
67 Amsavalli 43 H 4483 / 16 1             1     42     1               
68 Jehabar nachiya 45 H 4540 / 16 1             1   1 42     1               
69 Selvi 41 H 4576 / 16           1     1 1 36     1               
70 Rajammal 55 H 4450 / 16                 1 1 PM             1       
71 Clara 60 H 4646 / 16       1         1 1 PM             1       
111 
72 Amudha 39 H 4728 / 16 1             1     25   1                 
73 Subarammal 49 H 4761 / 16 1             1     30 1                   
74 Anjalai 46 H 4844 / 16 1             1     22   1                 
75 Punitha 43 H 4903 / 16   1           1     20     1               
76 Thilagavathy 42 H 5038 / 16 1               1   16   1                 
77 Latha 35 H 5105 / 16       1         1   13       1             
78 Senthamil selvi 50 H 5067 / 16       1         1   8 1                   
79 Anjalai 48 H 5066 / 16       1         1   9 1                   
80 Indhira 32 H 4759 / 16 1             1     34     1               
81 Manimegalai 40 H 5120 / 16 1             1     32       1             
82 Saroja 40 H 5123 / 16 1             1   1 28     1               
83 Jeenath Begam 44 H 5141 / 16 1             1     46         1           
84 Rajeswari 41 H 5144 / 16 1             1     48     1               
85 Tamilselvi 57 H 5158 / 16 1             1     PM             1       
86 Reetha 67 H 5170 / 16 1             1     PM             1       
87 Thangamani 47 H 5219 / 16 1             1     28     1               
88 Jenitha 42 H 5287 / 16 1             1     30     1               
89 Rajalakshmi 45 H 352 / 17 1               1   10   1                 
90 Revathy 43 H 2 / 17 1             1     58     1               
91 Selvi 49 H 122 / 17 1             1   1 6       1             
92 Anandha gowri 45 H 158 / 17   1           1   1 44     1               
93 Arayee 35 H 227 / 17 1             1     44     1               
94 Habibu Nisha 46 H 277 / 17   1           1     28         1           
95 Jayanthi 45 H 299 / 17 1             1     15   1                 
96 Kalaiselvi 42 H 760 / 17 1             1   1 42     1               
97 Rajeswari 32 H 755 / 17       1         1   38   1                 
98 Banu 40 H 752 / 17 1             1   1 22   1                 
99 Rajathi 37 H 735 / 17   1           1   1 14         1           
100 Nirmala 47 H 653 / 17         1       1   54       1             
101 Kogilavani 36 H 620 / 17 1               1   47   1                 
102 Pushpam 52 H 607 / 17       1         1 1 PM         1           
103 Petchiammal 55 H 606 / 17 1             1   1 20   1                 
104 Backiyam 50 H 571 / 17       1         1   7   1                 
105 Valli 46 H 570 / 17 1             1     20   1                 
106 Ambiga 40 H 530 / 17 1             1   1 22       1             
107 Tamilarasi 45 H 531 / 17 1             1     44   1                 
108 Dhanalakshmi 48 H 529 / 17 1             1     60       1             
109 Andars Mary 40 H 492 / 17 1               1   34   1                 
110 Kannammal 58 H 478 / 17 1             1     PM                 1   
111 Maheswari 40 H 476 / 17 1             1     22       1             
112 Alagammal 51 H 460 / 17 1             1     PM             1       
112 
113 Selvi 43 H 456 / 17 1             1     28         1           
114 Srividhya 40 H 438 / 17 1             1   1 32 1                   
115 Selvi 45 H 436 / 17   1           1     22 1                   
116 Malathi 46 H 419 / 17 1             1     24         1           
117 Rasammal 40 H 405 / 17 1             1     30         1           
118 Thavamani 43 H 402 / 17 1             1   1 8   1                 
119 Dhanalakshmi 46 H 397 / 17 1             1   1 34         1           
120 Susila 44 H 796 / 17 1             1     40     1               
121 Jebakumari 46 H 836 / 17 1               1 1 32   1                 
122 Vembu 47 H 843 / 17 1             1     38   1                 
123 Mariyayee 51 H 854 / 17   1           1   1 44     1               
124 Panjavarnam 35 H 855 / 17 1             1     56     1               
125 Manjula 36 H 856 / 17 1             1     28   1                 
126 Indhira Gandhi 42 H 870 / 17 1               1   30       1             
127 Radha 47 H 873 / 17 1             1     29   1                 
128 Savariyayee 48 H 927 / 17 1             1     25   1                 
129 Sagunthala 45 H 933 / 17 1             1   1 18   1                 
130 Pappathy 53 H 949 / 17 1             1     PM         1           
131 Pattu 45 H 999 / 17 1             1   1 26   1                 
132 Caroline 53 H 1030 / 17 1               1 1 PM   1                 
133 Amutha 42 H 1053 / 17 1             1     14   1                 
134 Jaya 55 H 1059 / 17   1             1 1 14   1                 
135 Aamena 40 H 1077 / 17     1           1   26   1                 
136 Anjalai 48 H 1078 / 17 1             1   1 32     1               
137 Kamala 49 H 1113 / 17 1             1   1 11     1               
138 Elanjium 43 H 1169 / 17     1         1     15   1                 
139 Noorjahan 41 H 1170 / 17   1             1 1 11 1                   
140 Fajhulla 43 H 1222 / 17 1               1 1 28   1                 
141 Mookayee 38 H 1263 / 17 1             1     6 1                   
142 Sampoornam 45 H 1270 / 17 1             1   1 42           1         
143 Mumthaj 50 H 1686 / 17 1             1   1 7 1                   
144 Chithra 45 H 1683 / 17     1         1     13   1                 
145 Shanthi 33 H 1666 / 17 1             1     21   1                 
146 Chitra 43 H 1662 / 17 1             1     24   1                 
147 Dhanaselvi 39 H 1661 / 17     1         1   1 7 1                   
148 Iyyanaramma 46 H 1584 / 17       1         1   20   1                 
149 Usharani 37 H 1559 / 17             1   1 1 5   1                 
150 Amuthavalli 43 H 1541 / 17       1         1   25     1               
151 Saroja 40 H 1517 / 17 1             1     13       1             
152 Vellaiyammal 46 H 1507 / 17 1             1   1 24   1                 
153 Vijayalakshmi 40 H 1399 / 17         1       1   28   1                 
113 
154 Bhavani 42 H 1398 / 17           1     1 1 22 1                   
155 Rajakumari 43 H 1392 / 17       1         1   32     1               
156 Revathy 45 H 1379 / 17   1           1   1 30 1                   
157 Thayamuthu 41 H 1358 / 17           1     1   PM 1                   
158 Patchayammal 38 H 1333 / 17 1             1   1 30         1           
159 Malliga 38 H 1432 / 17 1               1   4   1                 
160 Nallammal 43 H 1453 / 17         1       1   39   1                 
161 Vijaya 45 H 1452 / 17         1       1   14 1                   
162 Dhariamani 56 H 2912 / 17 1             1     12         1           
163 Parameshwari 43 H 2937 / 17     1         1   1 PM 1                   
164 Vellaiyammal 40 H 2938 / 17     1         1   1 26   1                 
165 Suba 39 H 2968 / 17 1             1   1 22       1             
166 Kameshwari 48 H 3009 / 17   1           1     34   1                 
167 Jackuline Mary 49 H 3013 / 17         1       1   24         1           
168 Selvi 45 H 3016 / 17 1             1   1 23       1             
169 Lakshmi 45 H 3163 / 17         1       1 1 15 1                   
170 Kannagi 46 H 3035 / 17     1         1     12   1                 
171 Jothi 43 H 3160 / 17 1             1   1 24       1             
172 Kamaladevi 39 H 3211 / 17     1         1     30 1                   
173 Santha 41 H 3219 / 17     1         1     25   1                 
174 Ramayee 40 H 3220 / 17       1         1   15 1                   
175 Selvakumari 45 H 3229 / 17         1       1 1 18   1                 
176 Nirmala rani 42 H 3330 / 17 1             1   1 21 1                   
177 Arulmary 40 H 3325 / 17 1             1     24     1               
178 Poonkodi 45 H 3379 / 17             1   1 1 32         1           
179 Poovalagi 45 H 3348 / 17 1               1   34 1                   
180 Sagaya mary 43 H 3426 / 17   1             1 1 9       1             
181 Semila 35 H 3424 / 17 1             1     34 1                   
182 Anthoniyammal 45 H 2818 / 17 1             1     30             1       
183 Gajalakshmi 45 H 2821 / 17 1             1     18   1                 
184 Alphonse mary 45 H 2852 / 17 1             1     60         1           
185 Josephin 41 H 2856 / 17   1           1     9     1               
186 Dhavamani 56 H 2912 / 17   1           1     11         1           
187 Parameshwari 43 H 2937 / 17 1             1   1 PM 1                   
188 Rajalakshmi 47 H 2944 / 17 1             1     24   1                 
189 Amirtham 36 H 3501 / 17 1             1   1 12         1           
190 Seethalakshmi 44 H 3131 / 17       1         1   14         1           
191 Chandra 50 H 3141 / 17     1         1     PM             1       
192 Anandha valli 50 H 3156 / 17         1       1   PM             1       
193 Chinnamari 42 H 3492 / 17   1             1   22             1       
194 Anjugam 42 H 3573 / 17     1         1     25       1             
114 
195 Sivagami 53 H 3548 / 17             1   1   23   1                 
196 Vijaya 48 H 3496 / 17       1         1   33 1                   
197 Sanariyammal 48 H 3972 / 17 1             1     7 1                   
198 Arifa 38 H 3954 / 17 1             1     16 1                   
199 Vijaya 49 H 3953 / 17 1             1   1 28   1                 
200 Susila 48 H 3946 / 17         1       1 1 7   1                 
201 Jacquline 38 H 3887 / 17   1           1   1 10   1                 
202 Poovayee 45 H 3840 / 17 1               1   28     1               
203 Celine 48 H 3817 / 17 1             1   1 PM 1                   
204 Mehathaj Begam 36 H 3757 / 17       1         1 1 20     1               
205 Susila 39 H 3748 / 17 1             1     4 1                   
206 Dhanalakshmi 55 H 3745 / 17 1             1   1 40 1                   
207 Shanthi 45 H 3725 / 17   1           1   1 11   1                 
208 Elisabeth Rani 57 H 3675 / 17     1         1     10             1       
209 Nagajothy 39 H 3670 / 17   1           1   1 14   1                 
210 Amutha 40 H 3645 / 17 1             1   1 28     1               
211 Chitra 48 H 3624 / 17 1             1     24 1                   
212 Amudha 46 H 3618 / 17     1         1     60       1             
213 Saroja 43 H 3603 / 17 1             1   1 14   1                 
214 Nigar Suldhana 40 H 3598 / 17         1       1 1 15   1                 
215 Shanthi 48 H 3574 / 17     1         1   1 62     1               
216 Rani 40 H 448 7/ 17 1             1   1 17   1                 
217 Vijaya 49 H 4471 / 17   1           1   1 24   1                 
218 Shanthi 46 H 4455 / 17 1             1     26   1                 
219 Chitra 45 H 4444 / 17 1             1   1 28     1               
220 Vijaya 45 H 4430 / 17     1         1   1 20   1                 
221 Jegadeeswari 58 H 4426 / 17   1           1   1 PM             1       
222 Lalitha 45 H 4425 / 17       1         1   20       1             
223 Sagunthala 37 H 4366 / 17 1             1     20   1                 
224 Vennila mary 42 H 4346 / 17   1           1   1 PM 1                   
225 Annakili 46 H 4335 / 17       1       1   1 PM 1                   
226 Jayanthi 42 H 4318 / 17 1             1   1 20 1                   
227 Vigneswari 48 H 4301 / 17             1   1 1 17   1                 
228 Thilagavathy 44 H 4300 / 17     1         1   1 10         1           
229 Cellapappa 42 H 4296 / 17   1           1   1 17 1                   
230 Kamala 40 H 4248 / 17 1             1     64     1               
231 Rajammal 55 H 4231 / 17         1       1 1 46       1             
232 Sharulatha 43 H 4227 / 17 1             1   1 38 1                   
233 Shanthi 47 H 4179 / 17   1           1   1 19 1                   
234 Chitra 45 H 4159 / 17 1             1   1 26         1           
235 Amirtham 48 H 4096 / 17 1             1     32         1           
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236 Rajakumari 40 H 474 / 18   1           1   1 33     1               
237 Lucas Rexceline 50 H 406 / 18 1             1     PM             1       
238 Eshwari 42 H 448 / 18       1         1   17         1           
239 Chitra 42 H 449 / 18         1       1 1 13       1             
240 Lakshmi 37 H 459 / 18 1               1   11   1                 
241 Bajiriya 43 H 550 / 18   1           1   1 42         1           
242 Iruthayamary 42 H 564 / 18 1             1     PM             1       
243 Sumathy 45 H 551 / 18     1         1   1 5   1                 
244 Malliga 47 H 109 / 18   1           1     28             1       
245 Ramzan Begam 38 H 667 / 18   1             1   34   1                 
246 Chandra 44 H 849 / 18   1           1   1 18   1                 
247 Saraswathy 37 H 851 / 18 1             1     21         1           
248 Rani 39 H 953 / 18         1       1 1 6         1           
249 Backiyam 50 H 979 / 18       1         1   PM       1             
250 Susila 45 H 973 / 18 1             1     29               1     
 
 
